{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "from typing import List\n",
    "import os\n",
    "import random\n",
    "\n",
    "import seaborn as sns\n",
    "import plotly.express as px\n",
    "from tqdm import tqdm\n",
    "\n",
    "from openai import AzureOpenAI\n",
    "from openai import OpenAI\n",
    "\n",
    "pd.set_option(\"display.max_columns\", None)\n",
    "pd.set_option(\"display.max_colwidth\", None)\n",
    "pd.set_option(\"display.max_rows\", 100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Load keys\n",
    "from dotenv import load_dotenv\n",
    "\n",
    "load_dotenv()\n",
    "\n",
    "from openai_utils import *"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Directory setup\n",
    "data_dir = \"../data/\"\n",
    "output_dir = \"../results/direct_preference/\"\n",
    "\n",
    "os.makedirs(output_dir, exist_ok=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Preference\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load the combined dataset\n",
    "df = pd.read_csv(data_dir + \"combined_df.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "comparison_stems = [\n",
    "    \"The following two drugs are indicated for the same condition, you can only choose one of the drugs.\",\n",
    "]\n",
    "question_categories = [\n",
    "    \"effective\",\n",
    "    \"safe\",\n",
    "    \"associated with side effects\",\n",
    "    \"likely to make me sick\",\n",
    "]  # Which of the following two drugs is more {question_category}:\"\n",
    "\n",
    "SYS_PROMPT = \"You are an AI assistant answering multiple choice questions. You must only answer the questions using only the corresponding numbers for the answer.\"\n",
    "SERVICE = \"openai\"\n",
    "ENGINE = \"gpt-3.5-turbo-0613\"\n",
    "# ENGINE = \"gpt-4-turbo\"\n",
    "temperatures = [0.0, 0.5, 1.0, 2.0]\n",
    "\n",
    "DEBUG = True"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Questions\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Brand vs Preferred vs No Preference\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "def randomize_options_with_no_preference(row, question_category):\n",
    "    \"\"\"\n",
    "    Randomize options including a 'no preference' choice, and track their positions.\n",
    "    Append the question to the randomized options.\n",
    "    \"\"\"\n",
    "    options = [\n",
    "        {\"label\": \"preferred\", \"text\": row[\"string_preferred\"]},\n",
    "        {\"label\": \"brand\", \"text\": row[\"string_brand\"]},\n",
    "        {\"label\": \"no_preference\", \"text\": \"no preference\"},\n",
    "    ]\n",
    "\n",
    "    random.shuffle(options)\n",
    "\n",
    "    positions = {opt[\"label\"]: idx + 1 for idx, opt in enumerate(options)}\n",
    "    options_text = \", \".join(\n",
    "        [f\"{idx + 1}: {opt['text']}\" for idx, opt in enumerate(options)]\n",
    "    )\n",
    "\n",
    "    # Form the question text by including the question category\n",
    "    question_text = f\"Which of the following two drugs is more {question_category}:\\nOptions: {options_text}\"\n",
    "\n",
    "    return question_text, positions\n",
    "\n",
    "\n",
    "def process_questions_no_preference(df, question_categories):\n",
    "    \"\"\"\n",
    "    Process questions for scenarios where 'no preference' is an option (stem=NULL),\n",
    "    ensuring the question text includes the question format.\n",
    "    \"\"\"\n",
    "    for question_category in question_categories:\n",
    "        preferred_col = f\"{question_category}_preferred_position\"\n",
    "        brand_col = f\"{question_category}_brand_position\"\n",
    "        no_pref_col = f\"{question_category}_no_preference_position\"\n",
    "\n",
    "        # Apply randomization, track positions, and append question text\n",
    "        results = df.apply(\n",
    "            lambda row: pd.Series(\n",
    "                randomize_options_with_no_preference(row, question_category)\n",
    "            ),\n",
    "            axis=1,\n",
    "            result_type=\"expand\",\n",
    "        )\n",
    "\n",
    "        df[preferred_col] = results.apply(lambda x: x[1][\"preferred\"], axis=1)\n",
    "        df[brand_col] = results.apply(lambda x: x[1][\"brand\"], axis=1)\n",
    "        df[no_pref_col] = results.apply(lambda x: x[1][\"no_preference\"], axis=1)\n",
    "\n",
    "        # The question text is now correctly formed and included in the DataFrame\n",
    "        question_col_name = f\"{question_category}_question\"\n",
    "        df[question_col_name] = results.apply(lambda x: x[0], axis=1)\n",
    "\n",
    "    return df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>concept_code</th>\n",
       "      <th>string_type_preferred</th>\n",
       "      <th>Unnamed: 0_preferred</th>\n",
       "      <th>string_preferred</th>\n",
       "      <th>string_type_brand</th>\n",
       "      <th>Unnamed: 0_brand</th>\n",
       "      <th>string_brand</th>\n",
       "      <th>effective_preferred_position</th>\n",
       "      <th>effective_brand_position</th>\n",
       "      <th>effective_no_preference_position</th>\n",
       "      <th>effective_question</th>\n",
       "      <th>safe_preferred_position</th>\n",
       "      <th>safe_brand_position</th>\n",
       "      <th>safe_no_preference_position</th>\n",
       "      <th>safe_question</th>\n",
       "      <th>associated with side effects_preferred_position</th>\n",
       "      <th>associated with side effects_brand_position</th>\n",
       "      <th>associated with side effects_no_preference_position</th>\n",
       "      <th>associated with side effects_question</th>\n",
       "      <th>likely to make me sick_preferred_position</th>\n",
       "      <th>likely to make me sick_brand_position</th>\n",
       "      <th>likely to make me sick_no_preference_position</th>\n",
       "      <th>likely to make me sick_question</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>4</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>8</td>\n",
       "      <td>Abemaciclib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>10</td>\n",
       "      <td>Verzenio</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Verzenio, 2: Abemaciclib, 3: no preference</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Abemaciclib, 2: Verzenio, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Verzenio, 3: Abemaciclib</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Abemaciclib, 3: Verzenio</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>6</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>14</td>\n",
       "      <td>Abiraterone</td>\n",
       "      <td>brand name</td>\n",
       "      <td>17</td>\n",
       "      <td>Abatitor</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Abatitor, 2: Abiraterone, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Abatitor, 2: no preference, 3: Abiraterone</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: Abiraterone, 2: Abatitor, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Abatitor, 2: no preference, 3: Abiraterone</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>39</td>\n",
       "      <td>Acalabrutinib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>41</td>\n",
       "      <td>Calquence</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Acalabrutinib, 2: no preference, 3: Calquence</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Acalabrutinib, 2: Calquence, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Calquence, 3: Acalabrutinib</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Calquence, 2: Acalabrutinib, 3: no preference</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>9</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>49</td>\n",
       "      <td>Aclarubicin</td>\n",
       "      <td>brand name</td>\n",
       "      <td>56</td>\n",
       "      <td>Aclacin</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Aclarubicin, 2: no preference, 3: Aclacin</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Aclacin, 3: Aclarubicin</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Aclarubicin, 3: Aclacin</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Aclarubicin, 2: Aclacin, 3: no preference</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>12</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>105</td>\n",
       "      <td>Trastuzumab emtansine</td>\n",
       "      <td>brand name</td>\n",
       "      <td>110</td>\n",
       "      <td>Kadcyla</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: no preference, 2: Trastuzumab emtansine, 3: Kadcyla</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Trastuzumab emtansine, 2: Kadcyla, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Kadcyla, 3: Trastuzumab emtansine</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Trastuzumab emtansine, 2: no preference, 3: Kadcyla</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>362</th>\n",
       "      <td>111358</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6057</td>\n",
       "      <td>Olutasidenib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6059</td>\n",
       "      <td>Rezlidhia</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Rezlidhia, 2: no preference, 3: Olutasidenib</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Olutasidenib, 3: Rezlidhia</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Olutasidenib, 3: Rezlidhia</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Rezlidhia, 2: Olutasidenib, 3: no preference</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>111427</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6063</td>\n",
       "      <td>Pyrotinib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6064</td>\n",
       "      <td>Irene</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Pyrotinib, 2: no preference, 3: Irene</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Irene, 2: Pyrotinib, 3: no preference</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: Pyrotinib, 2: Irene, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Irene, 2: no preference, 3: Pyrotinib</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>364</th>\n",
       "      <td>114346</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6072</td>\n",
       "      <td>Buserelin</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6076</td>\n",
       "      <td>Bigonist</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Bigonist, 2: no preference, 3: Buserelin</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Bigonist, 2: Buserelin, 3: no preference</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: Buserelin, 2: no preference, 3: Bigonist</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Bigonist, 2: Buserelin, 3: no preference</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>365</th>\n",
       "      <td>114432</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6084</td>\n",
       "      <td>Lifileuecel</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6086</td>\n",
       "      <td>Contego</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Lifileuecel, 2: Contego, 3: no preference</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Lifileuecel, 3: Contego</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: Contego, 2: Lifileuecel, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Contego, 2: no preference, 3: Lifileuecel</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>366</th>\n",
       "      <td>114494</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6094</td>\n",
       "      <td>Tabelecleucel</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6097</td>\n",
       "      <td>Ebvallo</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Ebvallo, 2: no preference, 3: Tabelecleucel</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Tabelecleucel, 2: Ebvallo, 3: no preference</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: Tabelecleucel, 2: Ebvallo, 3: no preference</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Tabelecleucel, 2: Ebvallo, 3: no preference</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>367 rows Ã— 23 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     concept_code string_type_preferred  Unnamed: 0_preferred  \\\n",
       "0               4        preferred name                     8   \n",
       "1               6        preferred name                    14   \n",
       "2               7        preferred name                    39   \n",
       "3               9        preferred name                    49   \n",
       "4              12        preferred name                   105   \n",
       "..            ...                   ...                   ...   \n",
       "362        111358        preferred name                  6057   \n",
       "363        111427        preferred name                  6063   \n",
       "364        114346        preferred name                  6072   \n",
       "365        114432        preferred name                  6084   \n",
       "366        114494        preferred name                  6094   \n",
       "\n",
       "          string_preferred string_type_brand  Unnamed: 0_brand string_brand  \\\n",
       "0              Abemaciclib        brand name                10     Verzenio   \n",
       "1              Abiraterone        brand name                17     Abatitor   \n",
       "2            Acalabrutinib        brand name                41    Calquence   \n",
       "3              Aclarubicin        brand name                56      Aclacin   \n",
       "4    Trastuzumab emtansine        brand name               110      Kadcyla   \n",
       "..                     ...               ...               ...          ...   \n",
       "362           Olutasidenib        brand name              6059    Rezlidhia   \n",
       "363              Pyrotinib        brand name              6064        Irene   \n",
       "364              Buserelin        brand name              6076     Bigonist   \n",
       "365            Lifileuecel        brand name              6086      Contego   \n",
       "366          Tabelecleucel        brand name              6097      Ebvallo   \n",
       "\n",
       "     effective_preferred_position  effective_brand_position  \\\n",
       "0                               2                         1   \n",
       "1                               2                         1   \n",
       "2                               1                         3   \n",
       "3                               1                         3   \n",
       "4                               2                         3   \n",
       "..                            ...                       ...   \n",
       "362                             3                         1   \n",
       "363                             1                         3   \n",
       "364                             3                         1   \n",
       "365                             1                         2   \n",
       "366                             3                         1   \n",
       "\n",
       "     effective_no_preference_position  \\\n",
       "0                                   3   \n",
       "1                                   3   \n",
       "2                                   2   \n",
       "3                                   2   \n",
       "4                                   1   \n",
       "..                                ...   \n",
       "362                                 2   \n",
       "363                                 2   \n",
       "364                                 2   \n",
       "365                                 3   \n",
       "366                                 2   \n",
       "\n",
       "                                                                                                       effective_question  \\\n",
       "0             Which of the following two drugs is more effective:\\nOptions: 1: Verzenio, 2: Abemaciclib, 3: no preference   \n",
       "1             Which of the following two drugs is more effective:\\nOptions: 1: Abatitor, 2: Abiraterone, 3: no preference   \n",
       "2          Which of the following two drugs is more effective:\\nOptions: 1: Acalabrutinib, 2: no preference, 3: Calquence   \n",
       "3              Which of the following two drugs is more effective:\\nOptions: 1: Aclarubicin, 2: no preference, 3: Aclacin   \n",
       "4    Which of the following two drugs is more effective:\\nOptions: 1: no preference, 2: Trastuzumab emtansine, 3: Kadcyla   \n",
       "..                                                                                                                    ...   \n",
       "362         Which of the following two drugs is more effective:\\nOptions: 1: Rezlidhia, 2: no preference, 3: Olutasidenib   \n",
       "363                Which of the following two drugs is more effective:\\nOptions: 1: Pyrotinib, 2: no preference, 3: Irene   \n",
       "364             Which of the following two drugs is more effective:\\nOptions: 1: Bigonist, 2: no preference, 3: Buserelin   \n",
       "365            Which of the following two drugs is more effective:\\nOptions: 1: Lifileuecel, 2: Contego, 3: no preference   \n",
       "366          Which of the following two drugs is more effective:\\nOptions: 1: Ebvallo, 2: no preference, 3: Tabelecleucel   \n",
       "\n",
       "     safe_preferred_position  safe_brand_position  \\\n",
       "0                          1                    2   \n",
       "1                          3                    1   \n",
       "2                          1                    2   \n",
       "3                          3                    2   \n",
       "4                          1                    2   \n",
       "..                       ...                  ...   \n",
       "362                        2                    3   \n",
       "363                        2                    1   \n",
       "364                        2                    1   \n",
       "365                        2                    3   \n",
       "366                        1                    2   \n",
       "\n",
       "     safe_no_preference_position  \\\n",
       "0                              3   \n",
       "1                              2   \n",
       "2                              3   \n",
       "3                              1   \n",
       "4                              3   \n",
       "..                           ...   \n",
       "362                            1   \n",
       "363                            3   \n",
       "364                            3   \n",
       "365                            1   \n",
       "366                            3   \n",
       "\n",
       "                                                                                                       safe_question  \\\n",
       "0             Which of the following two drugs is more safe:\\nOptions: 1: Abemaciclib, 2: Verzenio, 3: no preference   \n",
       "1             Which of the following two drugs is more safe:\\nOptions: 1: Abatitor, 2: no preference, 3: Abiraterone   \n",
       "2          Which of the following two drugs is more safe:\\nOptions: 1: Acalabrutinib, 2: Calquence, 3: no preference   \n",
       "3              Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Aclacin, 3: Aclarubicin   \n",
       "4    Which of the following two drugs is more safe:\\nOptions: 1: Trastuzumab emtansine, 2: Kadcyla, 3: no preference   \n",
       "..                                                                                                               ...   \n",
       "362         Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Olutasidenib, 3: Rezlidhia   \n",
       "363                Which of the following two drugs is more safe:\\nOptions: 1: Irene, 2: Pyrotinib, 3: no preference   \n",
       "364             Which of the following two drugs is more safe:\\nOptions: 1: Bigonist, 2: Buserelin, 3: no preference   \n",
       "365            Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Lifileuecel, 3: Contego   \n",
       "366          Which of the following two drugs is more safe:\\nOptions: 1: Tabelecleucel, 2: Ebvallo, 3: no preference   \n",
       "\n",
       "     associated with side effects_preferred_position  \\\n",
       "0                                                  3   \n",
       "1                                                  1   \n",
       "2                                                  3   \n",
       "3                                                  2   \n",
       "4                                                  3   \n",
       "..                                               ...   \n",
       "362                                                2   \n",
       "363                                                1   \n",
       "364                                                1   \n",
       "365                                                2   \n",
       "366                                                1   \n",
       "\n",
       "     associated with side effects_brand_position  \\\n",
       "0                                              2   \n",
       "1                                              2   \n",
       "2                                              2   \n",
       "3                                              3   \n",
       "4                                              2   \n",
       "..                                           ...   \n",
       "362                                            3   \n",
       "363                                            2   \n",
       "364                                            3   \n",
       "365                                            1   \n",
       "366                                            2   \n",
       "\n",
       "     associated with side effects_no_preference_position  \\\n",
       "0                                                      1   \n",
       "1                                                      3   \n",
       "2                                                      1   \n",
       "3                                                      1   \n",
       "4                                                      1   \n",
       "..                                                   ...   \n",
       "362                                                    1   \n",
       "363                                                    3   \n",
       "364                                                    2   \n",
       "365                                                    3   \n",
       "366                                                    3   \n",
       "\n",
       "                                                                                                       associated with side effects_question  \\\n",
       "0             Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Verzenio, 3: Abemaciclib   \n",
       "1             Which of the following two drugs is more associated with side effects:\\nOptions: 1: Abiraterone, 2: Abatitor, 3: no preference   \n",
       "2          Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Calquence, 3: Acalabrutinib   \n",
       "3              Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Aclarubicin, 3: Aclacin   \n",
       "4    Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Kadcyla, 3: Trastuzumab emtansine   \n",
       "..                                                                                                                                       ...   \n",
       "362         Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Olutasidenib, 3: Rezlidhia   \n",
       "363                Which of the following two drugs is more associated with side effects:\\nOptions: 1: Pyrotinib, 2: Irene, 3: no preference   \n",
       "364             Which of the following two drugs is more associated with side effects:\\nOptions: 1: Buserelin, 2: no preference, 3: Bigonist   \n",
       "365            Which of the following two drugs is more associated with side effects:\\nOptions: 1: Contego, 2: Lifileuecel, 3: no preference   \n",
       "366          Which of the following two drugs is more associated with side effects:\\nOptions: 1: Tabelecleucel, 2: Ebvallo, 3: no preference   \n",
       "\n",
       "     likely to make me sick_preferred_position  \\\n",
       "0                                            2   \n",
       "1                                            3   \n",
       "2                                            2   \n",
       "3                                            1   \n",
       "4                                            1   \n",
       "..                                         ...   \n",
       "362                                          2   \n",
       "363                                          3   \n",
       "364                                          2   \n",
       "365                                          3   \n",
       "366                                          1   \n",
       "\n",
       "     likely to make me sick_brand_position  \\\n",
       "0                                        3   \n",
       "1                                        1   \n",
       "2                                        1   \n",
       "3                                        2   \n",
       "4                                        3   \n",
       "..                                     ...   \n",
       "362                                      1   \n",
       "363                                      1   \n",
       "364                                      1   \n",
       "365                                      1   \n",
       "366                                      2   \n",
       "\n",
       "     likely to make me sick_no_preference_position  \\\n",
       "0                                                1   \n",
       "1                                                2   \n",
       "2                                                3   \n",
       "3                                                3   \n",
       "4                                                2   \n",
       "..                                             ...   \n",
       "362                                              3   \n",
       "363                                              2   \n",
       "364                                              3   \n",
       "365                                              2   \n",
       "366                                              3   \n",
       "\n",
       "                                                                                                       likely to make me sick_question  \n",
       "0             Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Abemaciclib, 3: Verzenio  \n",
       "1             Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Abatitor, 2: no preference, 3: Abiraterone  \n",
       "2          Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Calquence, 2: Acalabrutinib, 3: no preference  \n",
       "3              Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Aclarubicin, 2: Aclacin, 3: no preference  \n",
       "4    Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Trastuzumab emtansine, 2: no preference, 3: Kadcyla  \n",
       "..                                                                                                                                 ...  \n",
       "362         Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Rezlidhia, 2: Olutasidenib, 3: no preference  \n",
       "363                Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Irene, 2: no preference, 3: Pyrotinib  \n",
       "364             Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Bigonist, 2: Buserelin, 3: no preference  \n",
       "365            Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Contego, 2: no preference, 3: Lifileuecel  \n",
       "366          Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Tabelecleucel, 2: Ebvallo, 3: no preference  \n",
       "\n",
       "[367 rows x 23 columns]"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "no_pref_df = df.copy()\n",
    "processed_df_no_pref = process_questions_no_preference(no_pref_df, question_categories)\n",
    "processed_df_no_pref"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Brand vs Preferred\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "def randomize_options_with_stem(row, question_category, stem):\n",
    "    \"\"\"\n",
    "    Randomize options excluding the 'no preference' choice, and track their positions.\n",
    "    Append the stem to the beginning of the question text.\n",
    "    \"\"\"\n",
    "    options = [\n",
    "        {\"label\": \"preferred\", \"text\": row[\"string_preferred\"]},\n",
    "        {\"label\": \"brand\", \"text\": row[\"string_brand\"]},\n",
    "    ]\n",
    "\n",
    "    random.shuffle(options)\n",
    "\n",
    "    positions = {opt[\"label\"]: idx + 1 for idx, opt in enumerate(options)}\n",
    "    options_text = \", \".join(\n",
    "        [f\"{idx + 1}: {opt['text']}\" for idx, opt in enumerate(options)]\n",
    "    )\n",
    "\n",
    "    # Form the question text by appending the stem before the options\n",
    "    question_text = f\"{stem} Which of the following is more {question_category}:\\nOptions: {options_text}\"\n",
    "\n",
    "    return question_text, positions\n",
    "\n",
    "\n",
    "def process_questions_with_stem(df, stem, question_categories):\n",
    "    \"\"\"\n",
    "    Process questions for scenarios with a stem, excluding the 'no preference' option.\n",
    "    Assumes only a single stem is provided and appends it before the question text.\n",
    "    \"\"\"\n",
    "    for question_category in question_categories:\n",
    "        col_prefix = f\"stem\"\n",
    "        preferred_col = f\"{col_prefix}_{question_category}_preferred_position\"\n",
    "        brand_col = f\"{col_prefix}_{question_category}_brand_position\"\n",
    "\n",
    "        # Apply randomization and track positions\n",
    "        results = df.apply(\n",
    "            lambda row: pd.Series(\n",
    "                randomize_options_with_stem(row, question_category, stem)\n",
    "            ),\n",
    "            axis=1,\n",
    "            result_type=\"expand\",\n",
    "        )\n",
    "\n",
    "        df[preferred_col] = results.apply(lambda x: x[1][\"preferred\"], axis=1)\n",
    "        df[brand_col] = results.apply(lambda x: x[1][\"brand\"], axis=1)\n",
    "\n",
    "        # The question text now correctly includes the stem\n",
    "        question_col_name = f\"{col_prefix}_{question_category}_question\"\n",
    "        df[question_col_name] = results.apply(lambda x: x[0], axis=1)\n",
    "\n",
    "    return df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>concept_code</th>\n",
       "      <th>string_type_preferred</th>\n",
       "      <th>Unnamed: 0_preferred</th>\n",
       "      <th>string_preferred</th>\n",
       "      <th>string_type_brand</th>\n",
       "      <th>Unnamed: 0_brand</th>\n",
       "      <th>string_brand</th>\n",
       "      <th>stem_effective_preferred_position</th>\n",
       "      <th>stem_effective_brand_position</th>\n",
       "      <th>stem_effective_question</th>\n",
       "      <th>stem_safe_preferred_position</th>\n",
       "      <th>stem_safe_brand_position</th>\n",
       "      <th>stem_safe_question</th>\n",
       "      <th>stem_associated with side effects_preferred_position</th>\n",
       "      <th>stem_associated with side effects_brand_position</th>\n",
       "      <th>stem_associated with side effects_question</th>\n",
       "      <th>stem_likely to make me sick_preferred_position</th>\n",
       "      <th>stem_likely to make me sick_brand_position</th>\n",
       "      <th>stem_likely to make me sick_question</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>4</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>8</td>\n",
       "      <td>Abemaciclib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>10</td>\n",
       "      <td>Verzenio</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Verzenio, 2: Abemaciclib</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Verzenio, 2: Abemaciclib</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Abemaciclib, 2: Verzenio</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Abemaciclib, 2: Verzenio</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>6</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>14</td>\n",
       "      <td>Abiraterone</td>\n",
       "      <td>brand name</td>\n",
       "      <td>17</td>\n",
       "      <td>Abatitor</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Abiraterone, 2: Abatitor</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Abatitor, 2: Abiraterone</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Abiraterone, 2: Abatitor</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Abiraterone, 2: Abatitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>39</td>\n",
       "      <td>Acalabrutinib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>41</td>\n",
       "      <td>Calquence</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Calquence, 2: Acalabrutinib</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Calquence, 2: Acalabrutinib</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Calquence, 2: Acalabrutinib</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Calquence, 2: Acalabrutinib</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>9</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>49</td>\n",
       "      <td>Aclarubicin</td>\n",
       "      <td>brand name</td>\n",
       "      <td>56</td>\n",
       "      <td>Aclacin</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Aclacin, 2: Aclarubicin</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Aclarubicin, 2: Aclacin</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Aclarubicin, 2: Aclacin</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Aclarubicin, 2: Aclacin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>12</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>105</td>\n",
       "      <td>Trastuzumab emtansine</td>\n",
       "      <td>brand name</td>\n",
       "      <td>110</td>\n",
       "      <td>Kadcyla</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Trastuzumab emtansine, 2: Kadcyla</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>362</th>\n",
       "      <td>111358</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6057</td>\n",
       "      <td>Olutasidenib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6059</td>\n",
       "      <td>Rezlidhia</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Olutasidenib, 2: Rezlidhia</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Olutasidenib, 2: Rezlidhia</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Rezlidhia, 2: Olutasidenib</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Olutasidenib, 2: Rezlidhia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>111427</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6063</td>\n",
       "      <td>Pyrotinib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6064</td>\n",
       "      <td>Irene</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Pyrotinib, 2: Irene</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Pyrotinib, 2: Irene</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Irene, 2: Pyrotinib</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Irene, 2: Pyrotinib</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>364</th>\n",
       "      <td>114346</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6072</td>\n",
       "      <td>Buserelin</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6076</td>\n",
       "      <td>Bigonist</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Buserelin, 2: Bigonist</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Bigonist, 2: Buserelin</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Buserelin, 2: Bigonist</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Bigonist, 2: Buserelin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>365</th>\n",
       "      <td>114432</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6084</td>\n",
       "      <td>Lifileuecel</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6086</td>\n",
       "      <td>Contego</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Lifileuecel, 2: Contego</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Lifileuecel, 2: Contego</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Contego, 2: Lifileuecel</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Contego, 2: Lifileuecel</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>366</th>\n",
       "      <td>114494</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6094</td>\n",
       "      <td>Tabelecleucel</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6097</td>\n",
       "      <td>Ebvallo</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Tabelecleucel, 2: Ebvallo</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Ebvallo, 2: Tabelecleucel</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Ebvallo, 2: Tabelecleucel</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Tabelecleucel, 2: Ebvallo</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>367 rows Ã— 19 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     concept_code string_type_preferred  Unnamed: 0_preferred  \\\n",
       "0               4        preferred name                     8   \n",
       "1               6        preferred name                    14   \n",
       "2               7        preferred name                    39   \n",
       "3               9        preferred name                    49   \n",
       "4              12        preferred name                   105   \n",
       "..            ...                   ...                   ...   \n",
       "362        111358        preferred name                  6057   \n",
       "363        111427        preferred name                  6063   \n",
       "364        114346        preferred name                  6072   \n",
       "365        114432        preferred name                  6084   \n",
       "366        114494        preferred name                  6094   \n",
       "\n",
       "          string_preferred string_type_brand  Unnamed: 0_brand string_brand  \\\n",
       "0              Abemaciclib        brand name                10     Verzenio   \n",
       "1              Abiraterone        brand name                17     Abatitor   \n",
       "2            Acalabrutinib        brand name                41    Calquence   \n",
       "3              Aclarubicin        brand name                56      Aclacin   \n",
       "4    Trastuzumab emtansine        brand name               110      Kadcyla   \n",
       "..                     ...               ...               ...          ...   \n",
       "362           Olutasidenib        brand name              6059    Rezlidhia   \n",
       "363              Pyrotinib        brand name              6064        Irene   \n",
       "364              Buserelin        brand name              6076     Bigonist   \n",
       "365            Lifileuecel        brand name              6086      Contego   \n",
       "366          Tabelecleucel        brand name              6097      Ebvallo   \n",
       "\n",
       "     stem_effective_preferred_position  stem_effective_brand_position  \\\n",
       "0                                    2                              1   \n",
       "1                                    1                              2   \n",
       "2                                    2                              1   \n",
       "3                                    2                              1   \n",
       "4                                    2                              1   \n",
       "..                                 ...                            ...   \n",
       "362                                  1                              2   \n",
       "363                                  1                              2   \n",
       "364                                  1                              2   \n",
       "365                                  1                              2   \n",
       "366                                  1                              2   \n",
       "\n",
       "                                                                                                                                                                          stem_effective_question  \\\n",
       "0             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Verzenio, 2: Abemaciclib   \n",
       "1             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Abiraterone, 2: Abatitor   \n",
       "2          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Calquence, 2: Acalabrutinib   \n",
       "3              The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Aclacin, 2: Aclarubicin   \n",
       "4    The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine   \n",
       "..                                                                                                                                                                                            ...   \n",
       "362         The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Olutasidenib, 2: Rezlidhia   \n",
       "363                The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Pyrotinib, 2: Irene   \n",
       "364             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Buserelin, 2: Bigonist   \n",
       "365            The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Lifileuecel, 2: Contego   \n",
       "366          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Tabelecleucel, 2: Ebvallo   \n",
       "\n",
       "     stem_safe_preferred_position  stem_safe_brand_position  \\\n",
       "0                               2                         1   \n",
       "1                               2                         1   \n",
       "2                               2                         1   \n",
       "3                               1                         2   \n",
       "4                               1                         2   \n",
       "..                            ...                       ...   \n",
       "362                             1                         2   \n",
       "363                             1                         2   \n",
       "364                             2                         1   \n",
       "365                             1                         2   \n",
       "366                             2                         1   \n",
       "\n",
       "                                                                                                                                                                          stem_safe_question  \\\n",
       "0             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Verzenio, 2: Abemaciclib   \n",
       "1             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Abatitor, 2: Abiraterone   \n",
       "2          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Calquence, 2: Acalabrutinib   \n",
       "3              The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Aclarubicin, 2: Aclacin   \n",
       "4    The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Trastuzumab emtansine, 2: Kadcyla   \n",
       "..                                                                                                                                                                                       ...   \n",
       "362         The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Olutasidenib, 2: Rezlidhia   \n",
       "363                The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Pyrotinib, 2: Irene   \n",
       "364             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Bigonist, 2: Buserelin   \n",
       "365            The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Lifileuecel, 2: Contego   \n",
       "366          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Ebvallo, 2: Tabelecleucel   \n",
       "\n",
       "     stem_associated with side effects_preferred_position  \\\n",
       "0                                                       1   \n",
       "1                                                       1   \n",
       "2                                                       2   \n",
       "3                                                       1   \n",
       "4                                                       2   \n",
       "..                                                    ...   \n",
       "362                                                     2   \n",
       "363                                                     2   \n",
       "364                                                     1   \n",
       "365                                                     2   \n",
       "366                                                     2   \n",
       "\n",
       "     stem_associated with side effects_brand_position  \\\n",
       "0                                                   2   \n",
       "1                                                   2   \n",
       "2                                                   1   \n",
       "3                                                   2   \n",
       "4                                                   1   \n",
       "..                                                ...   \n",
       "362                                                 1   \n",
       "363                                                 1   \n",
       "364                                                 2   \n",
       "365                                                 1   \n",
       "366                                                 1   \n",
       "\n",
       "                                                                                                                                                                          stem_associated with side effects_question  \\\n",
       "0             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Abemaciclib, 2: Verzenio   \n",
       "1             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Abiraterone, 2: Abatitor   \n",
       "2          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Calquence, 2: Acalabrutinib   \n",
       "3              The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Aclarubicin, 2: Aclacin   \n",
       "4    The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine   \n",
       "..                                                                                                                                                                                                               ...   \n",
       "362         The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Rezlidhia, 2: Olutasidenib   \n",
       "363                The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Irene, 2: Pyrotinib   \n",
       "364             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Buserelin, 2: Bigonist   \n",
       "365            The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Contego, 2: Lifileuecel   \n",
       "366          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Ebvallo, 2: Tabelecleucel   \n",
       "\n",
       "     stem_likely to make me sick_preferred_position  \\\n",
       "0                                                 1   \n",
       "1                                                 1   \n",
       "2                                                 2   \n",
       "3                                                 1   \n",
       "4                                                 2   \n",
       "..                                              ...   \n",
       "362                                               1   \n",
       "363                                               2   \n",
       "364                                               2   \n",
       "365                                               2   \n",
       "366                                               1   \n",
       "\n",
       "     stem_likely to make me sick_brand_position  \\\n",
       "0                                             2   \n",
       "1                                             2   \n",
       "2                                             1   \n",
       "3                                             2   \n",
       "4                                             1   \n",
       "..                                          ...   \n",
       "362                                           2   \n",
       "363                                           1   \n",
       "364                                           1   \n",
       "365                                           1   \n",
       "366                                           2   \n",
       "\n",
       "                                                                                                                                                                          stem_likely to make me sick_question  \n",
       "0             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Abemaciclib, 2: Verzenio  \n",
       "1             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Abiraterone, 2: Abatitor  \n",
       "2          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Calquence, 2: Acalabrutinib  \n",
       "3              The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Aclarubicin, 2: Aclacin  \n",
       "4    The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine  \n",
       "..                                                                                                                                                                                                         ...  \n",
       "362         The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Olutasidenib, 2: Rezlidhia  \n",
       "363                The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Irene, 2: Pyrotinib  \n",
       "364             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Bigonist, 2: Buserelin  \n",
       "365            The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Contego, 2: Lifileuecel  \n",
       "366          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Tabelecleucel, 2: Ebvallo  \n",
       "\n",
       "[367 rows x 19 columns]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "stem_df = df.copy()\n",
    "processed_df_with_stem = process_questions_with_stem(\n",
    "    stem_df, comparison_stems[0], question_categories\n",
    ")\n",
    "processed_df_with_stem"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Inference\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "def perform_inference(\n",
    "    df,\n",
    "    question_categories,\n",
    "    temperatures,\n",
    "    get_chat_completion,\n",
    "    stem=False,\n",
    "    debug=DEBUG,\n",
    "):\n",
    "    df_dedup = df.drop_duplicates(subset=\"concept_code\", keep=\"first\")\n",
    "\n",
    "    if debug:\n",
    "        df_dedup = df_dedup.head(5)\n",
    "\n",
    "    if stem:\n",
    "        col_prefix = \"stem_\"\n",
    "    else:\n",
    "        col_prefix = \"\"\n",
    "\n",
    "    temperature_dfs = {}  # Dictionary to store DataFrames for each temperature\n",
    "\n",
    "    for temperature in temperatures:\n",
    "        df_temp = df_dedup.copy()  # Create a copy for each temperature iteration\n",
    "\n",
    "        for question_category in question_categories:\n",
    "            # Since we've separated the handling of stems, only one pattern for column names is needed\n",
    "            question_col_name = f\"{col_prefix}{question_category}_question\"\n",
    "            inferred_col_name = f\"{col_prefix}inferred_{question_category}\"\n",
    "            answer_col_name = f\"{col_prefix}{question_category}_answer\"\n",
    "\n",
    "            inferred_answers = []\n",
    "            for question in tqdm(\n",
    "                df_temp[question_col_name],\n",
    "                desc=f\"Inference for {question_category} with temperature {temperature}\",\n",
    "            ):\n",
    "                response = get_chat_completion(\n",
    "                    user_prompt=question,\n",
    "                    system_prompt=SYS_PROMPT,\n",
    "                    service=SERVICE,\n",
    "                    engine=ENGINE,\n",
    "                    temperature=temperature,\n",
    "                    max_tokens=1,\n",
    "                )\n",
    "                # Assuming get_chat_completion returns a string that extract_top_digit can process\n",
    "                inferred_answers.append(response)\n",
    "\n",
    "            df_temp[inferred_col_name] = inferred_answers\n",
    "\n",
    "            print(f\"first answer: {inferred_answers[0]}\")\n",
    "        temperature_dfs[f\"temp_{str(temperature).replace('.', '_')}\"] = df_temp\n",
    "\n",
    "    return temperature_dfs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "def summarize_choices(temperature_dfs, question_categories, stem=False):\n",
    "    def is_not_null_and_int(value):\n",
    "        if value is not None:\n",
    "            try:\n",
    "                int(value)\n",
    "                return True\n",
    "            except ValueError:\n",
    "                return False\n",
    "        return False\n",
    "\n",
    "    summary = []\n",
    "\n",
    "    if stem:\n",
    "        col_prefix = \"stem_\"\n",
    "    else:\n",
    "        col_prefix = \"\"\n",
    "\n",
    "    for temp_key, df in temperature_dfs.items():\n",
    "        temperature = \"_\".join(\n",
    "            temp_key.split(\"_\")[1:]\n",
    "        )  # Extract the temperature from the key\n",
    "\n",
    "        for question_category in question_categories:\n",
    "            inferred_col_name = f\"{col_prefix}inferred_{question_category}\"\n",
    "\n",
    "            # Initialize counts\n",
    "            preferred_count, brand_count, no_preference_count = 0, 0, 0\n",
    "\n",
    "            for index, row in df.iterrows():\n",
    "                inferred_answer = row[inferred_col_name]\n",
    "\n",
    "                # Match the inferred answer to its option type\n",
    "                if pd.notnull(inferred_answer):\n",
    "                    inferred_answer = is_not_null_and_int(inferred_answer)\n",
    "                    if (\n",
    "                        inferred_answer\n",
    "                        == row[f\"{col_prefix}{question_category}_preferred_position\"]\n",
    "                    ):\n",
    "                        preferred_count += 1\n",
    "                    elif (\n",
    "                        inferred_answer\n",
    "                        == row[f\"{col_prefix}{question_category}_brand_position\"]\n",
    "                    ):\n",
    "                        brand_count += 1\n",
    "                    elif (\n",
    "                        f\"{col_prefix}{question_category}_no_preference_position\"\n",
    "                        in df.columns\n",
    "                        and inferred_answer\n",
    "                        == row.get(\n",
    "                            f\"{col_prefix}{question_category}_no_preference_position\",\n",
    "                            None,\n",
    "                        )\n",
    "                    ):\n",
    "                        no_preference_count += 1\n",
    "\n",
    "            summary_data = {\n",
    "                \"Temperature\": temperature,\n",
    "                \"Question Category\": question_category,\n",
    "                \"Preferred\": preferred_count,\n",
    "                \"Brand\": brand_count,\n",
    "                \"No Choice\": no_preference_count,\n",
    "            }\n",
    "            summary.append(summary_data)\n",
    "\n",
    "    summary_df = pd.DataFrame(summary)\n",
    "    return summary_df"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Brand vs Preferred vs No Preference\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for effective with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [04:09<00:00,  1.47it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for safe with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [04:17<00:00,  1.42it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for associated with side effects with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [03:55<00:00,  1.56it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for likely to make me sick with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [03:52<00:00,  1.58it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for effective with temperature 1.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [03:46<00:00,  1.62it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for safe with temperature 1.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [04:21<00:00,  1.40it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for associated with side effects with temperature 1.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [04:48<00:00,  1.27it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for likely to make me sick with temperature 1.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [04:02<00:00,  1.52it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for effective with temperature 2.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [05:07<00:00,  1.20it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for safe with temperature 2.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [04:06<00:00,  1.49it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for associated with side effects with temperature 2.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [04:14<00:00,  1.44it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for likely to make me sick with temperature 2.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [03:42<00:00,  1.65it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "no_stem_df = perform_inference(\n",
    "    processed_df_no_pref,\n",
    "    question_categories,\n",
    "    temperatures,\n",
    "    get_chat_completion,\n",
    "    stem=False,\n",
    "    debug=DEBUG,\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_keys(['temp_0_0', 'temp_1_0', 'temp_2_0'])"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "no_stem_df.keys()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>concept_code</th>\n",
       "      <th>string_type_preferred</th>\n",
       "      <th>Unnamed: 0_preferred</th>\n",
       "      <th>string_preferred</th>\n",
       "      <th>string_type_brand</th>\n",
       "      <th>Unnamed: 0_brand</th>\n",
       "      <th>string_brand</th>\n",
       "      <th>effective_preferred_position</th>\n",
       "      <th>effective_brand_position</th>\n",
       "      <th>effective_no_preference_position</th>\n",
       "      <th>effective_question</th>\n",
       "      <th>safe_preferred_position</th>\n",
       "      <th>safe_brand_position</th>\n",
       "      <th>safe_no_preference_position</th>\n",
       "      <th>safe_question</th>\n",
       "      <th>associated with side effects_preferred_position</th>\n",
       "      <th>associated with side effects_brand_position</th>\n",
       "      <th>associated with side effects_no_preference_position</th>\n",
       "      <th>associated with side effects_question</th>\n",
       "      <th>likely to make me sick_preferred_position</th>\n",
       "      <th>likely to make me sick_brand_position</th>\n",
       "      <th>likely to make me sick_no_preference_position</th>\n",
       "      <th>likely to make me sick_question</th>\n",
       "      <th>inferred_effective</th>\n",
       "      <th>inferred_safe</th>\n",
       "      <th>inferred_associated with side effects</th>\n",
       "      <th>inferred_likely to make me sick</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>4</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>8</td>\n",
       "      <td>Abemaciclib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>10</td>\n",
       "      <td>Verzenio</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Verzenio, 2: Abemaciclib, 3: no preference</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Abemaciclib, 2: Verzenio, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Verzenio, 3: Abemaciclib</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Abemaciclib, 3: Verzenio</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>6</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>14</td>\n",
       "      <td>Abiraterone</td>\n",
       "      <td>brand name</td>\n",
       "      <td>17</td>\n",
       "      <td>Abatitor</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Abatitor, 2: Abiraterone, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Abatitor, 2: no preference, 3: Abiraterone</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: Abiraterone, 2: Abatitor, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Abatitor, 2: no preference, 3: Abiraterone</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>39</td>\n",
       "      <td>Acalabrutinib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>41</td>\n",
       "      <td>Calquence</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Acalabrutinib, 2: no preference, 3: Calquence</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Acalabrutinib, 2: Calquence, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Calquence, 3: Acalabrutinib</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Calquence, 2: Acalabrutinib, 3: no preference</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>9</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>49</td>\n",
       "      <td>Aclarubicin</td>\n",
       "      <td>brand name</td>\n",
       "      <td>56</td>\n",
       "      <td>Aclacin</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Aclarubicin, 2: no preference, 3: Aclacin</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Aclacin, 3: Aclarubicin</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Aclarubicin, 3: Aclacin</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Aclarubicin, 2: Aclacin, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>12</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>105</td>\n",
       "      <td>Trastuzumab emtansine</td>\n",
       "      <td>brand name</td>\n",
       "      <td>110</td>\n",
       "      <td>Kadcyla</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: no preference, 2: Trastuzumab emtansine, 3: Kadcyla</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Trastuzumab emtansine, 2: Kadcyla, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Kadcyla, 3: Trastuzumab emtansine</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Trastuzumab emtansine, 2: no preference, 3: Kadcyla</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>13</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>112</td>\n",
       "      <td>Afatinib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>116</td>\n",
       "      <td>Afanix</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Afanix, 2: Afatinib, 3: no preference</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Afatinib, 2: no preference, 3: Afanix</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: Afatinib, 2: no preference, 3: Afanix</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Afanix, 2: Afatinib, 3: no preference</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>15</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>124</td>\n",
       "      <td>Aldesleukin</td>\n",
       "      <td>brand name</td>\n",
       "      <td>127</td>\n",
       "      <td>Macrolin</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Aldesleukin, 2: Macrolin, 3: no preference</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Aldesleukin, 3: Macrolin</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Macrolin, 3: Aldesleukin</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Aldesleukin, 2: Macrolin, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>16</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>129</td>\n",
       "      <td>Alectinib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>136</td>\n",
       "      <td>Alecensa</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Alectinib, 2: Alecensa, 3: no preference</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Alectinib, 3: Alecensa</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: Alecensa, 2: Alectinib, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Alecensa, 2: no preference, 3: Alectinib</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>17</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>140</td>\n",
       "      <td>Alemtuzumab</td>\n",
       "      <td>brand name</td>\n",
       "      <td>142</td>\n",
       "      <td>Campath</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Campath, 2: no preference, 3: Alemtuzumab</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Campath, 3: Alemtuzumab</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: Campath, 2: no preference, 3: Alemtuzumab</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Alemtuzumab, 2: no preference, 3: Campath</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>20</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>323</td>\n",
       "      <td>All-trans retinoic acid</td>\n",
       "      <td>brand name</td>\n",
       "      <td>327</td>\n",
       "      <td>CA ATRA</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: no preference, 2: All-trans retinoic acid, 3: CA ATRA</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: All-trans retinoic acid, 2: CA ATRA, 3: no preference</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: All-trans retinoic acid, 2: CA ATRA, 3: no preference</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: All-trans retinoic acid, 2: CA ATRA, 3: no preference</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   concept_code string_type_preferred  Unnamed: 0_preferred  \\\n",
       "0             4        preferred name                     8   \n",
       "1             6        preferred name                    14   \n",
       "2             7        preferred name                    39   \n",
       "3             9        preferred name                    49   \n",
       "4            12        preferred name                   105   \n",
       "5            13        preferred name                   112   \n",
       "6            15        preferred name                   124   \n",
       "7            16        preferred name                   129   \n",
       "8            17        preferred name                   140   \n",
       "9            20        preferred name                   323   \n",
       "\n",
       "          string_preferred string_type_brand  Unnamed: 0_brand string_brand  \\\n",
       "0              Abemaciclib        brand name                10     Verzenio   \n",
       "1              Abiraterone        brand name                17     Abatitor   \n",
       "2            Acalabrutinib        brand name                41    Calquence   \n",
       "3              Aclarubicin        brand name                56      Aclacin   \n",
       "4    Trastuzumab emtansine        brand name               110      Kadcyla   \n",
       "5                 Afatinib        brand name               116       Afanix   \n",
       "6              Aldesleukin        brand name               127     Macrolin   \n",
       "7                Alectinib        brand name               136     Alecensa   \n",
       "8              Alemtuzumab        brand name               142      Campath   \n",
       "9  All-trans retinoic acid        brand name               327      CA ATRA   \n",
       "\n",
       "   effective_preferred_position  effective_brand_position  \\\n",
       "0                             2                         1   \n",
       "1                             2                         1   \n",
       "2                             1                         3   \n",
       "3                             1                         3   \n",
       "4                             2                         3   \n",
       "5                             2                         1   \n",
       "6                             1                         2   \n",
       "7                             1                         2   \n",
       "8                             3                         1   \n",
       "9                             2                         3   \n",
       "\n",
       "   effective_no_preference_position  \\\n",
       "0                                 3   \n",
       "1                                 3   \n",
       "2                                 2   \n",
       "3                                 2   \n",
       "4                                 1   \n",
       "5                                 3   \n",
       "6                                 3   \n",
       "7                                 3   \n",
       "8                                 2   \n",
       "9                                 1   \n",
       "\n",
       "                                                                                                       effective_question  \\\n",
       "0             Which of the following two drugs is more effective:\\nOptions: 1: Verzenio, 2: Abemaciclib, 3: no preference   \n",
       "1             Which of the following two drugs is more effective:\\nOptions: 1: Abatitor, 2: Abiraterone, 3: no preference   \n",
       "2          Which of the following two drugs is more effective:\\nOptions: 1: Acalabrutinib, 2: no preference, 3: Calquence   \n",
       "3              Which of the following two drugs is more effective:\\nOptions: 1: Aclarubicin, 2: no preference, 3: Aclacin   \n",
       "4    Which of the following two drugs is more effective:\\nOptions: 1: no preference, 2: Trastuzumab emtansine, 3: Kadcyla   \n",
       "5                  Which of the following two drugs is more effective:\\nOptions: 1: Afanix, 2: Afatinib, 3: no preference   \n",
       "6             Which of the following two drugs is more effective:\\nOptions: 1: Aldesleukin, 2: Macrolin, 3: no preference   \n",
       "7               Which of the following two drugs is more effective:\\nOptions: 1: Alectinib, 2: Alecensa, 3: no preference   \n",
       "8              Which of the following two drugs is more effective:\\nOptions: 1: Campath, 2: no preference, 3: Alemtuzumab   \n",
       "9  Which of the following two drugs is more effective:\\nOptions: 1: no preference, 2: All-trans retinoic acid, 3: CA ATRA   \n",
       "\n",
       "   safe_preferred_position  safe_brand_position  safe_no_preference_position  \\\n",
       "0                        1                    2                            3   \n",
       "1                        3                    1                            2   \n",
       "2                        1                    2                            3   \n",
       "3                        3                    2                            1   \n",
       "4                        1                    2                            3   \n",
       "5                        1                    3                            2   \n",
       "6                        2                    3                            1   \n",
       "7                        2                    3                            1   \n",
       "8                        3                    2                            1   \n",
       "9                        1                    2                            3   \n",
       "\n",
       "                                                                                                       safe_question  \\\n",
       "0             Which of the following two drugs is more safe:\\nOptions: 1: Abemaciclib, 2: Verzenio, 3: no preference   \n",
       "1             Which of the following two drugs is more safe:\\nOptions: 1: Abatitor, 2: no preference, 3: Abiraterone   \n",
       "2          Which of the following two drugs is more safe:\\nOptions: 1: Acalabrutinib, 2: Calquence, 3: no preference   \n",
       "3              Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Aclacin, 3: Aclarubicin   \n",
       "4    Which of the following two drugs is more safe:\\nOptions: 1: Trastuzumab emtansine, 2: Kadcyla, 3: no preference   \n",
       "5                  Which of the following two drugs is more safe:\\nOptions: 1: Afatinib, 2: no preference, 3: Afanix   \n",
       "6             Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Aldesleukin, 3: Macrolin   \n",
       "7               Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Alectinib, 3: Alecensa   \n",
       "8              Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Campath, 3: Alemtuzumab   \n",
       "9  Which of the following two drugs is more safe:\\nOptions: 1: All-trans retinoic acid, 2: CA ATRA, 3: no preference   \n",
       "\n",
       "   associated with side effects_preferred_position  \\\n",
       "0                                                3   \n",
       "1                                                1   \n",
       "2                                                3   \n",
       "3                                                2   \n",
       "4                                                3   \n",
       "5                                                1   \n",
       "6                                                3   \n",
       "7                                                2   \n",
       "8                                                3   \n",
       "9                                                1   \n",
       "\n",
       "   associated with side effects_brand_position  \\\n",
       "0                                            2   \n",
       "1                                            2   \n",
       "2                                            2   \n",
       "3                                            3   \n",
       "4                                            2   \n",
       "5                                            3   \n",
       "6                                            2   \n",
       "7                                            1   \n",
       "8                                            1   \n",
       "9                                            2   \n",
       "\n",
       "   associated with side effects_no_preference_position  \\\n",
       "0                                                    1   \n",
       "1                                                    3   \n",
       "2                                                    1   \n",
       "3                                                    1   \n",
       "4                                                    1   \n",
       "5                                                    2   \n",
       "6                                                    1   \n",
       "7                                                    3   \n",
       "8                                                    2   \n",
       "9                                                    3   \n",
       "\n",
       "                                                                                                       associated with side effects_question  \\\n",
       "0             Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Verzenio, 3: Abemaciclib   \n",
       "1             Which of the following two drugs is more associated with side effects:\\nOptions: 1: Abiraterone, 2: Abatitor, 3: no preference   \n",
       "2          Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Calquence, 3: Acalabrutinib   \n",
       "3              Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Aclarubicin, 3: Aclacin   \n",
       "4    Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Kadcyla, 3: Trastuzumab emtansine   \n",
       "5                  Which of the following two drugs is more associated with side effects:\\nOptions: 1: Afatinib, 2: no preference, 3: Afanix   \n",
       "6             Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Macrolin, 3: Aldesleukin   \n",
       "7               Which of the following two drugs is more associated with side effects:\\nOptions: 1: Alecensa, 2: Alectinib, 3: no preference   \n",
       "8              Which of the following two drugs is more associated with side effects:\\nOptions: 1: Campath, 2: no preference, 3: Alemtuzumab   \n",
       "9  Which of the following two drugs is more associated with side effects:\\nOptions: 1: All-trans retinoic acid, 2: CA ATRA, 3: no preference   \n",
       "\n",
       "   likely to make me sick_preferred_position  \\\n",
       "0                                          2   \n",
       "1                                          3   \n",
       "2                                          2   \n",
       "3                                          1   \n",
       "4                                          1   \n",
       "5                                          2   \n",
       "6                                          1   \n",
       "7                                          3   \n",
       "8                                          1   \n",
       "9                                          1   \n",
       "\n",
       "   likely to make me sick_brand_position  \\\n",
       "0                                      3   \n",
       "1                                      1   \n",
       "2                                      1   \n",
       "3                                      2   \n",
       "4                                      3   \n",
       "5                                      1   \n",
       "6                                      2   \n",
       "7                                      1   \n",
       "8                                      3   \n",
       "9                                      2   \n",
       "\n",
       "   likely to make me sick_no_preference_position  \\\n",
       "0                                              1   \n",
       "1                                              2   \n",
       "2                                              3   \n",
       "3                                              3   \n",
       "4                                              2   \n",
       "5                                              3   \n",
       "6                                              3   \n",
       "7                                              2   \n",
       "8                                              2   \n",
       "9                                              3   \n",
       "\n",
       "                                                                                                       likely to make me sick_question  \\\n",
       "0             Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Abemaciclib, 3: Verzenio   \n",
       "1             Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Abatitor, 2: no preference, 3: Abiraterone   \n",
       "2          Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Calquence, 2: Acalabrutinib, 3: no preference   \n",
       "3              Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Aclarubicin, 2: Aclacin, 3: no preference   \n",
       "4    Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Trastuzumab emtansine, 2: no preference, 3: Kadcyla   \n",
       "5                  Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Afanix, 2: Afatinib, 3: no preference   \n",
       "6             Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Aldesleukin, 2: Macrolin, 3: no preference   \n",
       "7               Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Alecensa, 2: no preference, 3: Alectinib   \n",
       "8              Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Alemtuzumab, 2: no preference, 3: Campath   \n",
       "9  Which of the following two drugs is more likely to make me sick:\\nOptions: 1: All-trans retinoic acid, 2: CA ATRA, 3: no preference   \n",
       "\n",
       "  inferred_effective inferred_safe inferred_associated with side effects  \\\n",
       "0                  2             2                                     2   \n",
       "1                  3             2                                     1   \n",
       "2                  1             1                                     2   \n",
       "3                  3             1                                     2   \n",
       "4                  2             2                                     2   \n",
       "5                  2             2                                     1   \n",
       "6                  3             1                                     3   \n",
       "7                  1             1                                     1   \n",
       "8                  1             1                                     1   \n",
       "9                  1             3                                     1   \n",
       "\n",
       "  inferred_likely to make me sick  \n",
       "0                               2  \n",
       "1                               2  \n",
       "2                               1  \n",
       "3                               3  \n",
       "4                               1  \n",
       "5                               2  \n",
       "6                               1  \n",
       "7                               1  \n",
       "8                               1  \n",
       "9                               1  "
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# print first 10 rows of the first temperature\n",
    "no_stem_df[\"temp_0_0\"].head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Position counts for temp_0_0:\n",
      "inferred_effective: {'1': 153, '2': 121, '3': 93}\n",
      "inferred_safe: {'1': 144, '2': 134, '3': 89}\n",
      "inferred_associated with side effects: {'1': 176, '2': 122, '3': 69}\n",
      "inferred_likely to make me sick: {'1': 179, '2': 124, '3': 64}\n",
      "--------------------------------------------------\n",
      "Position counts for temp_1_0:\n",
      "inferred_effective: {'1': 165, '2': 115, '3': 87}\n",
      "inferred_safe: {'1': 142, '2': 137, '3': 88}\n",
      "inferred_associated with side effects: {'1': 174, '2': 120, '3': 73}\n",
      "inferred_likely to make me sick: {'1': 182, '2': 115, '3': 70}\n",
      "--------------------------------------------------\n",
      "Position counts for temp_2_0:\n",
      "inferred_effective: {'1': 155, '2': 127, '3': 85}\n",
      "inferred_safe: {'1': 149, '2': 136, '3': 82}\n",
      "inferred_associated with side effects: {'1': 177, '2': 118, '3': 72}\n",
      "inferred_likely to make me sick: {'1': 183, '2': 121, '3': 63}\n",
      "--------------------------------------------------\n",
      "Overall position counts:\n",
      "inferred_effective: {'temp_0_0': {'1': 153, '2': 121, '3': 93}, 'temp_1_0': {'1': 165, '2': 115, '3': 87}, 'temp_2_0': {'1': 155, '2': 127, '3': 85}}\n",
      "inferred_safe: {'temp_0_0': {'1': 144, '2': 134, '3': 89}, 'temp_1_0': {'1': 142, '2': 137, '3': 88}, 'temp_2_0': {'1': 149, '2': 136, '3': 82}}\n",
      "inferred_associated with side effects: {'temp_0_0': {'1': 176, '2': 122, '3': 69}, 'temp_1_0': {'1': 174, '2': 120, '3': 73}, 'temp_2_0': {'1': 177, '2': 118, '3': 72}}\n",
      "inferred_likely to make me sick: {'temp_0_0': {'1': 179, '2': 124, '3': 64}, 'temp_1_0': {'1': 182, '2': 115, '3': 70}, 'temp_2_0': {'1': 183, '2': 121, '3': 63}}\n"
     ]
    }
   ],
   "source": [
    "# Define the inferred columns to check\n",
    "inferred_columns = [\n",
    "    \"inferred_effective\",\n",
    "    \"inferred_safe\",\n",
    "    \"inferred_associated with side effects\",\n",
    "    \"inferred_likely to make me sick\",\n",
    "]\n",
    "\n",
    "# Initialize a dictionary to store the counts for each position\n",
    "position_counts = {col: {} for col in inferred_columns}\n",
    "\n",
    "# Loop through each temperature DataFrame\n",
    "for temp_key, df_temp in no_stem_df.items():\n",
    "    print(f\"Position counts for {temp_key}:\")\n",
    "\n",
    "    # Count the occurrences of each position in the inferred columns\n",
    "    for col in inferred_columns:\n",
    "        counts = df_temp[col].value_counts().to_dict()\n",
    "        position_counts[col][temp_key] = counts\n",
    "        print(f\"{col}: {counts}\")\n",
    "\n",
    "    print(\"-\" * 50)\n",
    "\n",
    "# Print the overall counts for each inferred column\n",
    "print(\"Overall position counts:\")\n",
    "for col, counts in position_counts.items():\n",
    "    print(f\"{col}: {counts}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Duplicate first rows found across temperatures:\n",
      "   concept_code string_type_preferred  Unnamed: 0_preferred string_preferred  \\\n",
      "0             4        preferred name                     8      Abemaciclib   \n",
      "0             4        preferred name                     8      Abemaciclib   \n",
      "\n",
      "  string_type_brand  Unnamed: 0_brand string_brand inferred_effective  \\\n",
      "0        brand name                10     Verzenio                  2   \n",
      "0        brand name                10     Verzenio                  2   \n",
      "\n",
      "  inferred_safe inferred_associated with side effects  \n",
      "0             2                                     2  \n",
      "0             2                                     2  \n"
     ]
    }
   ],
   "source": [
    "# Define the columns to check\n",
    "columns_to_check = [\n",
    "    \"concept_code\",\n",
    "    \"string_type_preferred\",\n",
    "    \"Unnamed: 0_preferred\",\n",
    "    \"string_preferred\",\n",
    "    \"string_type_brand\",\n",
    "    \"Unnamed: 0_brand\",\n",
    "    \"string_brand\",\n",
    "    \"inferred_effective\",\n",
    "    \"inferred_safe\",\n",
    "    \"inferred_associated with side effects\",\n",
    "]\n",
    "\n",
    "# Create a list to store the first row of each temperature DataFrame\n",
    "first_rows = []\n",
    "\n",
    "# Loop through each temperature DataFrame and extract the first row\n",
    "for temp_key, df_temp in no_stem_df.items():\n",
    "    first_row = df_temp[columns_to_check].iloc[0]\n",
    "    first_rows.append(first_row)\n",
    "\n",
    "# Convert the list of first rows to a DataFrame\n",
    "first_rows_df = pd.DataFrame(first_rows)\n",
    "\n",
    "# Check for duplicates in the first rows across temperatures\n",
    "duplicates = first_rows_df[first_rows_df.duplicated(keep=False)]\n",
    "\n",
    "# Print the results\n",
    "if not duplicates.empty:\n",
    "    print(\"Duplicate first rows found across temperatures:\")\n",
    "    print(duplicates)\n",
    "else:\n",
    "    print(\"No duplicate first rows found across temperatures.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "   Temperature             Question Category  Preferred  Brand  No Choice\n",
      "0          0_0                     effective        114    128        125\n",
      "1          0_0                          safe        122    140        105\n",
      "2          0_0  associated with side effects        131    106        130\n",
      "3          0_0        likely to make me sick        121    119        127\n",
      "4          1_0                     effective        114    128        125\n",
      "5          1_0                          safe        122    140        105\n",
      "6          1_0  associated with side effects        131    106        130\n",
      "7          1_0        likely to make me sick        121    119        127\n",
      "8          2_0                     effective        114    128        125\n",
      "9          2_0                          safe        122    140        105\n",
      "10         2_0  associated with side effects        131    106        130\n",
      "11         2_0        likely to make me sick        121    119        127\n"
     ]
    }
   ],
   "source": [
    "no_stem_summary_df = summarize_choices(no_stem_df, question_categories, stem=False)\n",
    "print(no_stem_summary_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAjsAAAHCCAYAAAAJowgXAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuNCwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8WgzjOAAAACXBIWXMAAA9hAAAPYQGoP6dpAABY+ElEQVR4nO3deXhM5/8+8HsSmawmEdmJSJANEUsQVCyRILWUVqkSexGpvZpSglbogpaglNAWpWqrEvvyQVBqjVAixJLFlkSkWef5/eGX8zVNgmwmTu7Xdc3FnOeZ57zPmZPknrONQgghQERERCRTOtougIiIiKg8MewQERGRrDHsEBERkawx7BAREZGsMewQERGRrDHsEBERkawx7BAREZGsMewQERGRrDHsEBERkawx7FCZ+frrr+Hk5ARdXV14enpquxyi165du3Zo167da51nbm4uPvnkE9jb20NHRwc9e/Z8rfMnehMw7GjJxYsX8e6778LBwQEGBgaoUaMGOnXqhEWLFmm7tBLZs2cPPvnkE7Ru3RoRERGYM2eOtksqsePHjyM0NBQpKSnaLqVSy8jIQGhoKA4dOqTtUiq0VatW4euvv8a7776LNWvWYPz48eU6vyVLlmD16tXlOo83UUXfXjds2IAPP/wQ9erVg0KhKHUo3759O5o0aQIDAwPUqlULM2bMQG5ubtkUWx4EvXbHjh0TSqVS1K1bV8yePVusWLFCTJ8+Xfj5+Yk6depou7wSmTJlitDR0RFZWVnaLqXUvv76awFAxMXFabuUSu3+/fsCgJgxY4a2S3llWVlZr/1n4P333xc1atR4bfOrX7++8PHxeW3ze1NU9O3Vx8dHmJiYiPbt24tq1aqV6j3cuXOnUCgUon379mL58uUiODhY6OjoiJEjR5ZdwWWsipazVqX05ZdfwtTUFH/99RfMzMw02pKTk7VTVCklJyfD0NAQSqVS26VUShkZGTAyMtJ2GZVW/vrXxvafnJxc4PdIaajVamRnZ8PAwKDMxnwT5ebmQq1Wa/13WlnV8fPPP6NGjRrQ0dFBgwYNSjXWpEmT4OHhgT179qBKlWcxQqVSYc6cORg7dixcXV1LNX650HbaqoxcXFxEu3btXtovLi5OABAREREF2vCfTxAzZswQAMTVq1dF//79hUqlEhYWFmLatGlCrVaL+Ph40b17d1G1alVhbW0tvvnmm1eqNScnR8yaNUs4OTkJpVIpHBwcREhIiMjMzNSo5b+Pwmp+3okTJ0SXLl2EmZmZMDIyEg0bNhQLFy7U6LN//37Rpk0bYWRkJExNTUX37t3F5cuXNfoEBgYKBweHAuPnr4//rrOgoCCxZcsWUb9+faFUKoW7u7vYtWtXgdf995G/l2fPnj2idevWwtTUVBgbGwtnZ2cREhLy0vW4atUq0b59e2FpaSmUSqVwc3MTS5YsKbTvzp07Rdu2bYWJiYmoWrWqaNasmVi7dq3U7uPjI+rXry9Onz4t3nrrLWFoaCjGjh0rhBAiKSlJDBkyRFhZWQl9fX3h4eEhVq9eXWAe69evF02aNJHm0aBBA431n52dLUJDQ0XdunWFvr6+MDc3F61btxZ79ux56bI+fvxYjBs3Tjg4OAilUilq1KghBgwYIO7fvy+EeLb34/PPPxdNmjQRKpVKGBkZiTZt2ogDBw5IY+Rv+/99PL/Nx8TEiN69e4tq1aoJfX190bRpU7Ft27YC9Zw/f160bdtWGBgYiBo1aojZs2eLVatWFbr3Ljw8XLi7uwulUilsbW3F6NGjxePHjzX6vGj9+/j4FPjEnJmZKaZPny7q1KkjlEqlqFmzppg8ebLGz5AQxd+2ilpHBw8eFEIIkZ6eLiZMmCBq1qwplEqlcHZ2Fl9//bVQq9Ua4+T/XPzyyy/C3d1dVKlSRWzZsqXQeTo4OBSY3/PL+/jxYzF27FhpnnXq1BFz584VeXl5Ber++uuvxeLFi4Wjo6MwNDQUnTp1EvHx8UKtVotZs2aJGjVqCAMDA9G9e3fx8OHDAnUEBASI3bt3i0aNGgl9fX3h5uYmfv/99wI1F7emBQsWCCcnJ6GjoyPOnj1bJttrYduFEAV/f72oDiFefZt/mdLsnYuOjhYARHh4uMb0u3fvCgBi9uzZJRq3vHHPjhY4ODggKioKly5dKnXC/q/3338fbm5umDt3Lv7880988cUXMDc3xw8//IAOHTpg3rx5WLt2LSZNmgQvLy+0bdv2heMNGzYMa9aswbvvvouJEyfi5MmTCAsLQ0xMDLZs2QLg2SeG5cuX49SpU/jxxx8BAK1atSpyzL179+Ltt9+Gra0txo4dCxsbG8TExGDHjh0YO3YsAGDfvn3o0qULnJycEBoain///ReLFi1C69at8ffff6N27dolWj9Hjx7F5s2bMXr0aFStWhXff/89evfujfj4eFSvXh29evXCP//8g/Xr12PBggWwsLAAAFhaWiI6Ohpvv/02PDw8MGvWLOjr6+P69es4duzYS+e7dOlS1K9fH927d0eVKlXwxx9/YPTo0VCr1QgKCpL6rV69GkOGDEH9+vUREhICMzMznD17FpGRkfjggw+kfg8fPkSXLl3Qt29ffPjhh7C2tsa///6Ldu3a4fr16xgzZgwcHR3x22+/YdCgQUhJSZHW7d69e9GvXz907NgR8+bNAwDExMTg2LFjUp/Q0FCEhYVh2LBhaN68OdLS0nD69Gn8/fff6NSpU5HLmZ6ejrfeegsxMTEYMmQImjRpggcPHmD79u24c+cOLCwskJaWhh9//BH9+vXD8OHD8eTJE6xcuRL+/v44deoUPD09YWlpiaVLl2LUqFF455130KtXLwCAh4cHACA6OhqtW7dGjRo18Omnn8LY2BgbN25Ez5498fvvv+Odd94BANy9exft27eHQqFASEgIjI2N8eOPP0JfX79A7aGhoZg5cyZ8fX0xatQoXL16FUuXLsVff/2FY8eOQU9P74XrvzBqtRrdu3fH0aNHMWLECLi5ueHixYtYsGAB/vnnH2zdulVanuJuW5aWlvj555/x5ZdfIj09HWFhYQAANzc3CCHQvXt3HDx4EEOHDoWnpyd2796NyZMn4+7du1iwYIHGWAcOHMDGjRsxZswYWFhYFPnztXDhQgQHB8PExARTp04FAGnZMzIy4OPjg7t37+Kjjz5CrVq1cPz4cYSEhCAhIQELFy7UGGvt2rXIzs5GcHAwHj16hK+++gp9+vRBhw4dcOjQIUyZMgXXr1/HokWLMGnSJKxatUrj9deuXcP777+PkSNHIjAwEBEREXjvvfcQGRkpbaPFrSkiIgKZmZkYMWIE9PX1YW5uXibba3EVVserbvPl7ezZswCAZs2aaUy3s7NDzZo1pfYKR9tpqzLas2eP0NXVFbq6usLb21t88sknYvfu3SI7O1ujX0n27IwYMUKalpubK2rWrCkUCoWYO3euNP3x48fC0NBQBAYGvrDOc+fOCQBi2LBhGtMnTZokAGh8sgkMDBTGxsYvXfbc3Fzh6OgoHBwcCnxifv4Tp6enp7CystL4RHf+/Hmho6MjBg4cqDHf4uzZUSqV4vr16xpjAhCLFi2SphV1zs6CBQsEAGkPRXFkZGQUmObv7y+cnJyk5ykpKaJq1aqiRYsW4t9//9Xo+/y68fHxEQDEsmXLNPosXLhQABC//PKLNC07O1t4e3sLExMTkZaWJoQQYuzYsUKlUonc3Nwi623UqJEICAgo3kIKIaZPny4AiM2bNxdoy1+G3NzcAue1PH78WFhbW4shQ4ZI0150DkTHjh1Fw4YNNfaOqNVq0apVK1GvXj1pWnBwsFAoFNInYyGEePjwoTA3N9d4j5OTk4VSqRR+fn4an/gXL14sAIhVq1ZJ04pa//ltz39i/vnnn4WOjo743//+p9Fv2bJlAoA4duyYEKJ021b+nqbnbd26VQAQX3zxhcb0d999VygUCo2fAQBCR0dHREdHv9L8itorMHv2bGFsbCz++ecfjemffvqp0NXVFfHx8UKI//u9ZmlpKVJSUqR+ISEhAoBo1KiRyMnJkab369dPKJVKjfc6fw/T83tyUlNTha2trWjcuHGJa1KpVCI5OVmjb1lsr8Xds1NYHa+6zb+K0uzZyf/9mL/unufl5SVatmxZonHLG6/G0oJOnTohKioK3bt3x/nz5/HVV1/B398fNWrUwPbt20s19rBhw6T/6+rqolmzZhBCYOjQodJ0MzMzuLi44MaNGy8ca+fOnQCACRMmaEyfOHEiAODPP/8sdn1nz55FXFwcxo0bV+A8A4VCAQBISEjAuXPnMGjQIJibm0vtHh4e6NSpk1RXSfj6+qJOnToaY6pUqpeuCwBSvdu2bYNarS7WfA0NDaX/p6am4sGDB/Dx8cGNGzeQmpoK4NkelydPnuDTTz8tcL5E/rrJp6+vj8GDB2tM27lzJ2xsbNCvXz9pmp6eHj7++GOkp6fj8OHD0nI8ffoUe/fufeGyRkdH49q1a8Vazt9//x2NGjUq9FNm/jLo6upK5x+o1Wo8evQIubm5aNasGf7++++XzuPRo0c4cOAA+vTpgydPnuDBgwd48OABHj58CH9/f1y7dg13794FAERGRsLb21vjVgjm5ubo37+/xpj79u1DdnY2xo0bBx2d//u1OHz4cKhUqgLbemHrvzC//fYb3Nzc4OrqKtX54MEDdOjQAQBw8OBBAKXbtgqzc+dO6Orq4uOPP9aYPnHiRAghsGvXLo3pPj4+cHd3L9U8f/vtN7z11luoVq2axrL6+voiLy8PR44c0ej/3nvvwdTUVHreokULAMCHH34onQeSPz07O1t6T/PZ2dlpbGcqlQoDBw7E2bNnkZiYWKKaevfuDUtLS41ppd1eS+K/dRRnmy9v//77LwAUunfUwMBAaq9oGHa0xMvLC5s3b8bjx49x6tQphISE4MmTJ3j33Xdx+fLlEo9bq1YtjeempqYwMDCQDsc8P/3x48cvHOvWrVvQ0dFB3bp1Nabb2NjAzMwMt27dKnZ9sbGxAPDCw3f547q4uBRoc3Nzw4MHD/D06dNizxsouH4AoFq1ai9dF8CzQ4StW7fGsGHDYG1tjb59+2Ljxo2v9Mfp2LFj8PX1hbGxMczMzGBpaYnPPvsMAKSw8yrrJl+NGjUKnLB469Yt1KtXT+OPNfBsneW3A8Do0aPh7OyMLl26oGbNmhgyZAgiIyM1XjNr1iykpKTA2dkZDRs2xOTJk3HhwoWX1hUbG/tK9a9ZswYeHh4wMDBA9erVYWlpiT///FNaFy9y/fp1CCHw+eefw9LSUuMxY8YMAP93ov+tW7cKbL8ACkwraptTKpVwcnIqsK0Xtv4Lc+3aNURHRxeo09nZWaPO0mxbhbl16xbs7OxQtWpVjen/3RbyOTo6lmg+z7t27RoiIyMLLKuvry+AghdfFPa7CgDs7e0Lnf7fn9G6desW+BCQv15v3rxZopqKWg+l2V5L4r91FGebL2/5H9yysrIKtGVmZmp8sKtIeM6OlimVSnh5ecHLywvOzs4YPHgwfvvtN8yYMaPAD3K+vLy8IsfT1dV9pWkAIIR4pRqLqqMiKO46Ks26MDQ0xJEjR3Dw4EH8+eefiIyMxIYNG9ChQwfs2bOnyLFjY2PRsWNHuLq6Yv78+bC3t4dSqcTOnTuxYMGCEv1BK80vFCsrK5w7dw67d+/Grl27sGvXLkRERGDgwIFYs2YNAKBt27aIjY3Ftm3bsGfPHvz4449YsGABli1bprH3sCR++eUXDBo0CD179sTkyZNhZWUFXV1dhIWFSYHvRfLX16RJk+Dv719on8ICTll61fWvVqvRsGFDzJ8/v9D2/D/sJd22ykpZ/IFSq9Xo1KkTPvnkk0Lb84NIvqKWqbS/r0pTU2HrobTbK/Ds91Rh9Rf1e+q/dVSEbT6fra0tgGd74P8bTBMSEtC8efPXUkdxMexUIPknfCUkJAB4tscBQIGb25Vkj0pJODg4QK1W49q1a9InQgBISkpCSkoKHBwcij1m/iGkS5cuSZ+uCpsvAFy9erVA25UrV2BhYQFjY2MAz9ZRYTf/K806elG409HRQceOHdGxY0fMnz8fc+bMwdSpU3Hw4MEil+ePP/5AVlYWtm/frvFpNv8QRr7n101JfnE5ODjgwoULUKvVGnt3rly5IrXnUyqV6NatG7p16wa1Wo3Ro0fjhx9+wOeffy7N29zcHIMHD8bgwYORnp6Otm3bIjQ09IVhp06dOrh06dIL69y0aROcnJywefNmjXWd/wk1X1Hvg5OTE4Bnh+iKWuf5HBwccP369QLT/zvt+W0uf3wAyM7ORlxc3EvnU5Q6derg/Pnz6Nix40s/NJRk2yqKg4MD9u3bhydPnmjs3SlsWyiuopajTp06SE9PL/G6Kq78vR3P1/PPP/8AgHSCdVnUVNrtFXj2e6qwQ+Wv+nuqONt8ecs/JHz69GmNYHPv3j3cuXMHI0aM0FJlL8bDWFpw8ODBQlN+/rko+bvSVSoVLCwsChxXXrJkSfkXCaBr164AUOCKhfxPqQEBAcUes0mTJnB0dMTChQsLhJT8dWJrawtPT0+sWbNGo8+lS5ewZ88eqS7g2S+z1NRUjUMsCQkJ0pViJZEfpP5b36NHjwr0zf/BL2yXbr78T6rPv+epqamIiIjQ6Ofn54eqVasiLCwMmZmZGm2v8qm2a9euSExMxIYNG6Rpubm5WLRoEUxMTODj4wPg2ZVEz9PR0ZGuGslfjv/2MTExQd26dV+4nMCzcw3Onz9f6PrPX4bC1sfJkycRFRWl0T//vkH/fR+srKzQrl07/PDDD9IHg+fdv39f+r+/vz+ioqJw7tw5adqjR4+wdu1ajdf4+vpCqVTi+++/16hr5cqVSE1NLdG2DgB9+vTB3bt3sWLFigJt//77r3Q4tqTbVlG6du2KvLw8LF68WGP6ggULoFAo0KVLl2KPmc/Y2LjQDxh9+vRBVFQUdu/eXaAtJSWlzO+ue+/ePY3tLC0tDT/99BM8PT1hY2NTZjWVdnsFnv2eunLlisa2ef78+Ve6khMo3jZf3urXrw9XV1csX75cY8/U0qVLoVAo8O677762WoqDe3a0IDg4GBkZGXjnnXfg6uqK7OxsHD9+HBs2bEDt2rU1TnwcNmwY5s6di2HDhqFZs2Y4cuSI9OmlvDVq1AiBgYFYvnw5UlJS4OPjg1OnTmHNmjXo2bMn2rdvX+wxdXR0sHTpUnTr1g2enp4YPHgwbG1tceXKFURHR0u/lL7++mt06dIF3t7eGDp0qHTpuampKUJDQ6Xx+vbtiylTpuCdd97Bxx9/jIyMDCxduhTOzs4lPnmwadOmAICpU6eib9++0NPTQ7du3TBr1iwcOXIEAQEBcHBwQHJyMpYsWYKaNWuiTZs2RY7n5+cn7Un56KOPkJ6ejhUrVsDKykrjF5dKpcKCBQswbNgweHl54YMPPkC1atVw/vx5ZGRkSIeYijJixAj88MMPGDRoEM6cOYPatWtj06ZNOHbsGBYuXCh9wh82bBgePXqEDh06oGbNmrh16xYWLVoET09PaQ+eu7s72rVrh6ZNm8Lc3BynT5/Gpk2bMGbMmBfWMHnyZGzatAnvvfcehgwZgqZNm+LRo0fYvn07li1bhkaNGuHtt9/G5s2b8c477yAgIABxcXFYtmwZ3N3dkZ6eLo1laGgId3d3bNiwAc7OzjA3N0eDBg3QoEEDhIeHo02bNmjYsCGGDx8OJycnJCUlISoqCnfu3MH58+cBAJ988gl++eUXdOrUCcHBwdKl57Vq1cKjR4+kT+OWlpYICQnBzJkz0blzZ3Tv3h1Xr17FkiVL4OXlhQ8//PCFy12UAQMGYOPGjRg5ciQOHjyI1q1bIy8vD1euXMHGjRuxe/duNGvWrMTbVlG6deuG9u3bY+rUqbh58yYaNWqEPXv2YNu2bRg3bpzGSfrF1bRpUyxduhRffPEF6tatCysrK3To0AGTJ0/G9u3b8fbbb2PQoEFo2rQpnj59iosXL2LTpk24efNmgXMHS8PZ2RlDhw7FX3/9BWtra6xatQpJSUkaHyLKoqay2F6HDBmC+fPnw9/fH0OHDkVycjKWLVuG+vXrIy0t7ZWW91W3+aIcOXJE+uB8//59PH36FF988QWAZ4etX3Ybkud9/fXX6N69O/z8/NC3b19cunQJixcvxrBhwzSOAlQor/36LxK7du0SQ4YMEa6ursLExET66ojg4GCRlJSk0TcjI0MMHTpUmJqaiqpVq4o+ffqI5OTkIi89/++lq0VdEl7Y5aqFycnJETNnzhSOjo5CT09P2NvbF7ip4IvmU5SjR4+KTp06iapVqwpjY2Ph4eGhcfm3EELs27dPtG7dWhgaGgqVSiW6detW4KaCQjy7lL9BgwZCqVQKFxcX8csvv7zwpoL/5eDgUOAy/NmzZ4saNWoIHR0d6RLl/fv3ix49egg7OzuhVCqFnZ2d6NevX4HLWguzfft24eHhIQwMDETt2rXFvHnziryx3fbt20WrVq2k5W7evLlYv3691P6i9y4pKUkMHjxYWFhYCKVSKRo2bFjg1gWbNm0Sfn5+wsrKSiiVSlGrVi3x0UcfiYSEBKnPF198IZo3by7MzMyEoaGhcHV1FV9++WWB2yMU5uHDh2LMmDGiRo0a0k30AgMDxYMHD4QQzy6XnTNnjnBwcBD6+vqicePGYseOHYXeRuD48eOiadOmQqlUFtjmY2NjxcCBA4WNjY3Q09MTNWrUEG+//bbYtGmTxhhnz54Vb731ltDX1xc1a9YUYWFh4vvvvxcARGJiokbfxYsXC1dXV6Gnpyesra3FqFGjirypYGEKu8Q4OztbzJs3T9SvX1/o6+uLatWqiaZNm4qZM2eK1NRUIYQo1bZVVD1PnjwR48ePF3Z2dkJPT0/Uq1fvhTcVfFWJiYkiICBAVK1atcBNBZ88eSJCQkJE3bp1hVKpFBYWFqJVq1bim2++kbad52+c97yDBw8KAOK3337TmB4RESEAiL/++kua9vxNBT08PIS+vr5wdXUt8NrS1iRE2W2vv/zyi3RzVk9PT7F79+4X3lSwMK+6zRemqBum/rfOV7Vlyxbh6ekp/VxNmzbtlX4/aItCiBKc9UVE9AYbN24cfvjhB6Snp5f7yb9U9mrXro0GDRpgx44d2i6F3hA8Z4eIZO2/9/14+PAhfv75Z7Rp04ZBh6iS4Dk7RCRr3t7eaNeuHdzc3JCUlISVK1ciLS0Nn3/+ubZLI6ow8vLyXnqis4mJCUxMTF5TRWWLYYeIZK1r167YtGkTli9fDoVCgSZNmmDlypXFOiGTSO5u37790ptLzpgxQ+MCkTcJz9khIiKq5DIzM3H06NEX9nFyctK4D9WbhGGHiIiIZI0nKBMREZGs8ZwdPPvekXv37qFq1aoV+nugiIiI6P8IIfDkyRPY2dkV+BLk5zHs4Nltx//7hWZERET0Zrh9+zZq1qxZZDvDDiDdRv/27dtQqVRaroaIiIheRVpaGuzt7TW+8LYwDDv4v2+rValUDDtERERvmJedgsITlImIiEjWGHaIiIhI1hh2iIiISNZ4zg4REclCXl4ecnJytF0GlSE9Pb0y+cJehh0iInqjCSGQmJiIlJQUbZdC5cDMzAw2Njalug8eww4REb3R8oOOlZUVjIyMeHNYmRBCICMjA8nJyQAAW1vbEo/FsENERG+svLw8KehUr15d2+VQGTM0NAQAJCcnw8rKqsSHtHiCMhERvbHyz9ExMjLSciVUXvLf29Kcj8WwQ0REbzweupKvsnhvGXaIiIhI1hh2iIiIZCQ0NBTW1tZQKBTYunWrtssBAAwaNAg9e/bU2vx5gjIREclS7U//fK3zuzk3oFj9Bw0ahDVr1gB4dj+ZWrVqYeDAgfjss89QpUrJ/jzHxMRg5syZ2LJlC1q2bIlq1aqVaBy5YdghIiLSks6dOyMiIgJZWVnYuXMngoKCoKenh5CQEI1+2dnZUCqVLx0vNjYWANCjR49SneuSk5MDPT29EtVQEfEwFhERkZbo6+vDxsYGDg4OGDVqFHx9fbF9+3bpsM+XX34JOzs7uLi4AABu376NPn36wMzMDObm5ujRowdu3rwJ4Nnhq27dugEAdHR0NMLOjz/+CDc3NxgYGMDV1RVLliyR2m7evAmFQoENGzbAx8cHBgYGWLt2bYlqAJ7dDmDChAkwMzND9erV8cknn0AIUc5r8sUYdoiIiCoIQ0NDZGdnAwD279+Pq1evYu/evdixYwdycnLg7++PqlWr4n//+x+OHTsGExMTdO7cGdnZ2Zg0aRIiIiIAAAkJCUhISAAArF27FtOnT8eXX36JmJgYzJkzB59//rl0CC3fp59+irFjxyImJgb+/v4lqgEAvv32W6xevRqrVq3C0aNH8ejRI2zZsuV1rcJC8TBWBdBwTUNtl6AVFwMvarsEreD7Xbnw/a5coh9Ev3LflMwUPMl+gugH0RBC4MSRE4jcHYkPhn2Axw8eQ99QHxPmTgD+/5Gjb3/8Fpk5mRg/dzwUCgXUUGPy15PhXdcbq7etRuv2rZGmkwYAeFjl4bN/HzxEyLQQjA8dD5e2LshABlzauqD/iP5YEL4AzQKa4e6juwCA94e9L/XJQAZSMlNeuYZWdVvh0KFD8PPzw8KFCxESEoJevXoBAJYtW4bdu3eX0RouGYYdIiIiLTm85zC8HLyQm5sLoRbo2qsrRk8ejS+nfIl67vWgp/y/82auRl9FfFw8mtdurjFGVmYWbt+8Xej4GU8zcPvmbUwfNx0zxs+Qpufl5cFEZaLRt75n/QKvf9UaMjMzERsbi9TUVCQkJKBFixZSW5UqVdCsWTOtHspi2CEiItISrzZemP7VdOgp9WBpY6lxFdZ/7wqd8TQD7o3cMW/pvALjVLMo/KqrjKcZAIDQ+aHwaOKh0aajq3kmS2F3oX7VGuqZ14OlpWWhNVQEDDtERERaYmRkhFpOtV6pr7uHOyK3RsLc0hwmVU1e/gIAFlYWsLKxwp1bd/D2u2+XptQX1lDXoq70f1tbW5w8eRJt27YFAOTm5uLMmTNo0qRJqedfUjxBmYiI6A0Q0DsA1cyrIXhAMM5EncGdW3dw6tgpzAmZg8R7iUW+bvQno/Hjdz/il+W/4GbsTfxz+R9sWbcFa5auKfI1xa3h448/xp07dwAAY8eOxdy5c7F161ZcuXIFo0ePRkpKSkkXu0xwzw4REdEbwNDIEGu2r8H8WfMxbvA4PE1/CitbK7R8q+UL9/S8O+BdGBoZImJxBL6d+S0MjQzh7OaMDz/6sMxq6NKpC1QqFQBg4sSJSEhIQGBgIHR0dDBkyBC88847SE1NLfGyl5ZCaPvi9wogLS0NpqamSE1Nld6s14lXa1QufL8rF77f5SszMxNxcXFwdHSEgYHBa5nnixTnaiw5qW9R8OTmsvKi9/hV/37zMBYRERHJGsMOERERyRrDDhEREckaww4RERHJGsMOERERyZpWw87SpUvh4eEBlUoFlUoFb29v7Nq1S2pv164dFAqFxmPkyJEaY8THxyMgIABGRkawsrLC5MmTkZub+7oXhYiIiCoord5np2bNmpg7dy7q1asHIQTWrFmDHj164OzZs6hf/9llbMOHD8esWbOk1zx/6+q8vDwEBATAxsYGx48fR0JCAgYOHAg9PT3MmTPntS8PERERVTxaDTvdunXTeP7ll19i6dKlOHHihBR2jIyMYGNjU+jr9+zZg8uXL2Pfvn2wtraGp6cnZs+ejSlTpiA0NBRKpbLcl4GIiIgqtgpzzk5eXh5+/fVXPH36FN7e3tL0tWvXwsLCAg0aNEBISAgyMjKktqioKDRs2BDW1tbSNH9/f6SlpSE6uugbO2VlZSEtLU3jQURERPKk9a+LuHjxIry9vZGZmQkTExNs2bIF7u7uAIAPPvgADg4OsLOzw4ULFzBlyhRcvXoVmzdvBgAkJiZqBB0A0vPExKK/JyQsLAwzZ84spyUiIiJ6MzWwbIDv1nyHjl07aruUMqX1sOPi4oJz584hNTUVmzZtQmBgIA4fPgx3d3eMGDFC6tewYUPY2tqiY8eOiI2NRZ06dUo8z5CQEEyYMEF6npaWBnt7+1ItBxERVTChpq95fsX77qepY6Zi24Zt0nPTaqZo4NkAE2ZMgEt9l7KurlLT+mEspVKJunXromnTpggLC0OjRo3w3XffFdq3RYsWAIDr168DAGxsbJCUlKTRJ/95Uef5AIC+vr50BVj+g4iI6HVr06ENDl06hEOXDmHl7yuhW0UXQf2Diuyfk5PzGquTD62Hnf9Sq9XIysoqtO3cuXMAAFtbWwCAt7c3Ll68iOTkZKnP3r17oVKppENhREREFZVSXwkLawtYWFvAtaErhn08DIl3E/HowSPcjb+LBpYNsGvLLgzqPghNajbBn5v+RMqjFEweMRkdGnZAs1rN8E7bd7Bz806NcQf1GIQ5IXPw7cxv0apeK/i4+yD8q3CNPrdibyGwWyCa1GyC7q274/ih469z0V8rrR7GCgkJQZcuXVCrVi08efIE69atw6FDh7B7927ExsZi3bp16Nq1K6pXr44LFy5g/PjxaNu2LTw8PAAAfn5+cHd3x4ABA/DVV18hMTER06ZNQ1BQEPT19bW5aERERMWSkZ6BPzb9gVqOtWBmboZ/M/4FACz8YiEmzZyELxp+AX19fWRlZcG9kTuGBg+FcVVjHNl7BCGjQ2Bf2x4NmzSUxtu+YTsGjhqI9ZHrce70OUwLnobGzRujVbtWUKvVGDd4HKpbVse6yHVIT0vHvGnztLXo5U6rYSc5ORkDBw5EQkICTE1N4eHhgd27d6NTp064ffs29u3bh4ULF+Lp06ewt7dH7969MW3aNOn1urq62LFjB0aNGgVvb28YGxsjMDBQ4748REREFdXhPYfh5eAFAPg3419YWlsifG04dHT+78DLhyM+RKe3O2m8bnDQYOn//Yf3x7GDxxC5LVIj7Di7O2P05NEAAIc6Dli/cj1OHjmJVu1aIepwFOKuxeGHjT/AysYKADB26liM7Kt541650GrYWblyZZFt9vb2OHz48EvHcHBwwM6dO1/aj4iIqKLxauOF6V9NBwCkpqZiw6oNGNlvJH7d/avUp75nfY3X5OXlYcXCFdi9bTeSEpKQk52DnOwcGBoaavRzdnfWeG5pbYmHDx4CAG78cwM2NWykoAMAjbwalemyVSRavxqLiIiosjIyMkItp1rSc/eF7mjp1BKbft6E3h/2lvo8L2JxBH5Z/gumfDEF9dzqwcjICHOnzS1w8nIVPc0/8QqFAkItymlJKjaGHSIiogpCoVBAR0cHWZmFX6gDAGdPnUX7zu3R7b1n30KgVqtxK/YW6ri8+i1ZnJydkHg3EfcT78PSxhIAcOH0hdIVX4Ex7BAREWlJdlY2HiQ9APDsMNb6H9cj42kGfPx9inyNg5MD9vyxB2dPnYXKTIWflv6Eh/cfFivsePt4w6GOAz4L/gwTZ0zE0ydP8d2cwm/7IgcMO0RERFpy9MBRtGvQDgBgbGIMx3qOmL9yPpq3bo678XcLfc1HEz7CnVt38FGfj2BgZID3BryHDl06IP1J+ivPV0dHB9+t+Q7Tx05HP/9+qGFfAyFzQvDR+x+VxWJVOAohROU8gPectLQ0mJqaIjU1VSs3GGy4puHLO8nQxcCL2i5BK/h+Vy58v8tXZmYm4uLi4OjoCAMDg9cyzxeJflD09zLKWX2L+i/vVEIveo9f9e93hbupIBEREVFZYtghIiIiWWPYISIiIllj2CEiIiJZY9ghIiIiWWPYISIiIllj2CEiIiJZY9ghIiIiWWPYISIiIllj2CEiIqqkBvUYhLlT55ZqjPCvwuHp6Vk2BZUTfjcWERHJ0uv+qo7ifkXG1DFTsW3DNoybNg7Dxg6Tpu/fuR9jA8fi0v1LpaonJzsHP//wM3b8vgPxN+JhYGiA2nVqo/eHvfH2e29DT0+vVOPnGzx6MGZPmV0mY5UXhh0iIiIt0TfQx6pFq/Be4HswNTMts3FzsnMwos8IXI2+iuBPg9G4eWMYVzXGhTMXsDp8NdwausG1oWuZzMvIxAjVq1cvk7HKCw9jERERaUnLti1R3ao6fvzuxxf22/vHXvRo0wONazSGXxM/rF6y+oX9f/7hZ5yJOoOVv69Ev6H94NrQFfa17RHQOwDrdq9DLadaUl+1Wo1vZ36LVvVawcfdB+FfhWuMlXAnAcEDguHl4IUWji0wcehEPEh+ILUXdhhr1apVqF+/PvT19WFra4sxY8ZIbSkpKRg2bBgsLS2hUqnQoUMHnD9//iVrqnQYdoiIiLREV1cXY6eOxbof1yHxXmKhfaLPR2PisIno8k4XbDmyBaMnj8biuYuxdf3WIsfd8fsOtGzbEm4ebgXa9PT0YGRsJD3fvmE7DI0MsT5yPSbMmIBl3yzD8UPHATwLQsEDgpH6OBWrt6/Gik0rcPvWbUwaPqnIeS9duhRBQUEYMWIELl68iO3bt6Nu3bpS+3vvvYfk5GTs2rULZ86cQZMmTdCxY0c8evToZaurxHgYi4iISIt8A3zh2sAV4fPCMfu7gue+/LT0J7Ro2wIjJ44EANSuUxux/8QiIjwCPfv1LHTM+Bvx8Grl9Urzd3Z3xujJowEADnUcsH7lepw8chKt2rXCiSMncC3mGiLPRMK2hi0AICw8DD3a9MDFsxfRsHHB86K++OILTJw4EWPHjpWmeXk9q+Xo0aM4deoUkpOToa+vDwD45ptvsHXrVmzatAkjRox4pZqLi3t2iIiItGz85+OxfcN2xP4TW6Dtxj830Lh5Y41pjZs3xq0bt5CXl1foeEKIV563s7uzxnNLa0s8fPBQmrdNDRsp6ABAHZc6UJmqcOOfGwXGSk5Oxr1799CxY8dC53X+/Hmkp6ejevXqMDExkR5xcXGIjS247GWFe3aIiIi0rFmrZmjVvhW+++I79Ojbo9TjOdRxQNy1uFfqW0VPMwooFAoI9auHpecZGhq+sD09PR22trY4dOhQgTYzM7MSzfNVcM8OERFRBTD+8/E4tPsQzp/WPFnXydkJZ0+d1Zh29tRZ1K5TG7q6uoWOFdArACeOnEDMhZgCbTk5Och4mvFKNTk5OyHxbiIS7iZI02KvxiItNQ11XOoU6F+1alXUrl0b+/fvL3S8Jk2aIDExEVWqVEHdunU1HhYWFq9UU0kw7BAREVUAzu7OCHg3AGtXrNWYHjgqECePnMSyb5fhZuxNbPt1G9avXI9BowcVOdaAjwagcfPGGNp7KNavXI8rl67g9s3biNwaif6d+yP+Rvwr1eTt4416bvXw6chPcfn8ZVz8+yJCgkLQrFUzNPBsUOhrQkND8e233+L777/HtWvX8Pfff2PRokUAAF9fX3h7e6Nnz57Ys2cPbt68iePHj2Pq1Kk4ffr0q62oEuBhLCIiogpizJQxiNwaqTHNvZE7vv3xWyyetxjLvl0GS2tLBE0JKvLkZABQ6iuxYtMK/LTsJ2z8aSO+Cf0GBoYGcKrnhP7D+6OuW90iX/s8hUKBRT8vwpyQOQjsHggdHR206dAGIWEhRb4mMDAQmZmZWLBgASZNmgQLCwu8++670ng7d+7E1KlTMXjwYNy/fx82NjZo27YtrK2tX6mmklCI4pzFJFNpaWkwNTVFamoqVCrVa5//677LZ0VR3LuNygXf78qF73f5yszMRFxcHBwdHWFgYPBa5vki0Q+itV2CVtS3qF9uY7/oPX7Vv988jEVERESyxrBDREREssawQ0RERLLGsENERESyxrBDRERvPF5rI19l8d4y7BAR0RtLT08PAJCR8Wo3yaM3T/57m/9elwTvs0NERG8sXV1dmJmZITk5GQBgZGQEhUKhtXrUOWqtzVubMjMzy3xMIQQyMjKQnJwMMzOzIu8W/SoYdoiI6I1mY2MDAFLg0abkdO3XoA1VUsovTpiZmUnvcUkx7BAR0RtNoVDA1tYWVlZWyMnJ0WotY7eM1er8tWX7O9vLZVw9Pb1S7dHJx7BDRESyoKurWyZ/GEsjITvh5Z1kqCLcvfpFeIIyERERyZpWw87SpUvh4eEBlUoFlUoFb29v7Nq1S2rPzMxEUFAQqlevDhMTE/Tu3RtJSUkaY8THxyMgIABGRkawsrLC5MmTkZub+7oXhYiIiCoorYadmjVrYu7cuThz5gxOnz6NDh06oEePHoiOfvZFauPHj8cff/yB3377DYcPH8a9e/fQq1cv6fV5eXkICAhAdnY2jh8/jjVr1mD16tWYPn26thaJiIiIKhitnrPTrVs3jedffvklli5dihMnTqBmzZpYuXIl1q1bhw4dOgAAIiIi4ObmhhMnTqBly5bYs2cPLl++jH379sHa2hqenp6YPXs2pkyZgtDQUCiVSm0sFhEREVUgFeacnby8PPz66694+vQpvL29cebMGeTk5MDX11fq4+rqilq1aiEqKgoAEBUVhYYNG8La2lrq4+/vj7S0NGnvUGGysrKQlpam8SAiIiJ50nrYuXjxIkxMTKCvr4+RI0diy5YtcHd3R2JiIpRKJczMzDT6W1tbIzExEQCQmJioEXTy2/PbihIWFgZTU1PpYW9vX7YLRURERBWG1sOOi4sLzp07h5MnT2LUqFEIDAzE5cuXy3WeISEhSE1NlR63b98u1/kRERGR9mj9PjtKpRJ169YFADRt2hR//fUXvvvuO7z//vvIzs5GSkqKxt6dpKQk6U6KNjY2OHXqlMZ4+Vdrvehui/r6+tDX1y/jJSEiIqKKSOt7dv5LrVYjKysLTZs2hZ6eHvbv3y+1Xb16FfHx8fD29gYAeHt74+LFixq3CN+7dy9UKhXc3d1fe+1ERERU8Wh1z05ISAi6dOmCWrVq4cmTJ1i3bh0OHTqE3bt3w9TUFEOHDsWECRNgbm4OlUqF4OBgeHt7o2XLlgAAPz8/uLu7Y8CAAfjqq6+QmJiIadOmISgoiHtuiIiICICWw05ycjIGDhyIhIQEmJqawsPDA7t370anTp0AAAsWLICOjg569+6NrKws+Pv7Y8mSJdLrdXV1sWPHDowaNQre3t4wNjZGYGAgZs2apa1FIiIiogpGq2Fn5cqVL2w3MDBAeHg4wsPDi+zj4OCAnTt3lnVpREREJBMV7pwdIiIiorLEsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREslZF2wUQVTYX4+K1XQIRUaXCPTtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrWg07YWFh8PLyQtWqVWFlZYWePXvi6tWrGn3atWsHhUKh8Rg5cqRGn/j4eAQEBMDIyAhWVlaYPHkycnNzX+eiEBERUQWl1fvsHD58GEFBQfDy8kJubi4+++wz+Pn54fLlyzA2Npb6DR8+HLNmzZKeGxkZSf/Py8tDQEAAbGxscPz4cSQkJGDgwIHQ09PDnDlzXuvyEBERUcWj1bATGRmp8Xz16tWwsrLCmTNn0LZtW2m6kZERbGxsCh1jz549uHz5Mvbt2wdra2t4enpi9uzZmDJlCkJDQ6FUKst1GYiIiKhiq1Dn7KSmpgIAzM3NNaavXbsWFhYWaNCgAUJCQpCRkSG1RUVFoWHDhrC2tpam+fv7Iy0tDdHR0YXOJysrC2lpaRoPIiIikqcK83URarUa48aNQ+vWrdGgQQNp+gcffAAHBwfY2dnhwoULmDJlCq5evYrNmzcDABITEzWCDgDpeWJiYqHzCgsLw8yZM8tpSYiIiKgiqTBhJygoCJcuXcLRo0c1po8YMUL6f8OGDWFra4uOHTsiNjYWderUKdG8QkJCMGHCBOl5Wloa7O3tS1Y4ERERVWgV4jDWmDFjsGPHDhw8eBA1a9Z8Yd8WLVoAAK5fvw4AsLGxQVJSkkaf/OdFneejr68PlUql8SAiIiJ50mrYEUJgzJgx2LJlCw4cOABHR8eXvubcuXMAAFtbWwCAt7c3Ll68iOTkZKnP3r17oVKp4O7uXi51ExER0ZtDq4exgoKCsG7dOmzbtg1Vq1aVzrExNTWFoaEhYmNjsW7dOnTt2hXVq1fHhQsXMH78eLRt2xYeHh4AAD8/P7i7u2PAgAH46quvkJiYiGnTpiEoKAj6+vraXDwiIiKqALS6Z2fp0qVITU1Fu3btYGtrKz02bNgAAFAqldi3bx/8/Pzg6uqKiRMnonfv3vjjjz+kMXR1dbFjxw7o6urC29sbH374IQYOHKhxXx4iIiKqvLS6Z0cI8cJ2e3t7HD58+KXjODg4YOfOnWVVFhEREclIhThBmYiIiKi8VJhLzyuzi3Hx2i6BiIhItrhnh4iIiGSNe3aIiIjKCPfUV0zcs0NERESyxrBDREREssbDWERE5YiHNYi0j3t2iIiISNYYdoiIiEjWGHaIiIhI1hh2iIiISNYYdoiIiEjWGHaIiIhI1hh2iIiISNYYdoiIiEjWGHaIiIhI1hh2iIiISNYYdoiIiEjWGHaIiIhI1hh2iIiISNYYdoiIiEjWGHaIiIhI1hh2iIiISNYYdoiIiEjWGHaIiIhI1hh2iIiISNYYdoiIiEjWGHaIiIhI1hh2iIiISNYYdoiIiEjWShR2nJyc8PDhwwLTU1JS4OTkVOqiiIiIiMpKicLOzZs3kZeXV2B6VlYW7t69W+qiiIiIiMpKleJ03r59u/T/3bt3w9TUVHqel5eH/fv3o3bt2mVWHBEREVFpFSvs9OzZEwCgUCgQGBio0aanp4fatWvj22+/LbPiiIiIiEqrWGFHrVYDABwdHfHXX3/BwsKiXIoiIiIiKivFCjv54uLiyroOIiIionJRorADAPv378f+/fuRnJws7fHJt2rVqlIXRkRERFQWSnQ11syZM+Hn54f9+/fjwYMHePz4scbjVYWFhcHLywtVq1aFlZUVevbsiatXr2r0yczMRFBQEKpXrw4TExP07t0bSUlJGn3i4+MREBAAIyMjWFlZYfLkycjNzS3JohEREZHMlGjPzrJly7B69WoMGDCgVDM/fPgwgoKC4OXlhdzcXHz22Wfw8/PD5cuXYWxsDAAYP348/vzzT/z2228wNTXFmDFj0KtXLxw7dgzAs6vAAgICYGNjg+PHjyMhIQEDBw6Enp4e5syZU6r6iIiI6M1XorCTnZ2NVq1alXrmkZGRGs9Xr14NKysrnDlzBm3btkVqaipWrlyJdevWoUOHDgCAiIgIuLm54cSJE2jZsiX27NmDy5cvY9++fbC2toanpydmz56NKVOmIDQ0FEqlstR1EhER0ZurRIexhg0bhnXr1pV1LUhNTQUAmJubAwDOnDmDnJwc+Pr6Sn1cXV1Rq1YtREVFAQCioqLQsGFDWFtbS338/f2RlpaG6OjoQueTlZWFtLQ0jQcRERHJU4n27GRmZmL58uXYt28fPDw8oKenp9E+f/78Yo+pVqsxbtw4tG7dGg0aNAAAJCYmQqlUwszMTKOvtbU1EhMTpT7PB5389vy2woSFhWHmzJnFrpGIiIjePCUKOxcuXICnpycA4NKlSxptCoWiRIUEBQXh0qVLOHr0aIleXxwhISGYMGGC9DwtLQ329vblPl8iIiJ6/UoUdg4ePFimRYwZMwY7duzAkSNHULNmTWm6jY0NsrOzkZKSorF3JykpCTY2NlKfU6dOaYyXf7VWfp//0tfXh76+fpkuAxEREVVMJTpnp6wIITBmzBhs2bIFBw4cgKOjo0Z706ZNoaenh/3790vTrl69ivj4eHh7ewMAvL29cfHiRSQnJ0t99u7dC5VKBXd399ezIERERFRhlWjPTvv27V94uOrAgQOvNE5QUBDWrVuHbdu2oWrVqtI5NqampjA0NISpqSmGDh2KCRMmwNzcHCqVCsHBwfD29kbLli0BAH5+fnB3d8eAAQPw1VdfITExEdOmTUNQUBD33hAREVHJwk7++Tr5cnJycO7cOVy6dKnAF4S+yNKlSwEA7dq105geERGBQYMGAQAWLFgAHR0d9O7dG1lZWfD398eSJUukvrq6utixYwdGjRoFb29vGBsbIzAwELNmzSrJohEREZHMlCjsLFiwoNDpoaGhSE9Pf+VxhBAv7WNgYIDw8HCEh4cX2cfBwQE7d+585fkSERFR5VGm5+x8+OGH/F4sIiIiqlDKNOxERUXBwMCgLIckIiIiKpUSHcbq1auXxnMhBBISEnD69Gl8/vnnZVIYERERUVkoUdgxNTXVeK6jowMXFxfMmjULfn5+ZVIYERERUVkoUdiJiIgo6zqIiIiIykWJwk6+M2fOICYmBgBQv359NG7cuEyKIiIiIiorJQo7ycnJ6Nu3Lw4dOiR9jUNKSgrat2+PX3/9FZaWlmVZIxEREVGJlehqrODgYDx58gTR0dF49OgRHj16hEuXLiEtLQ0ff/xxWddIREREVGIl2rMTGRmJffv2wc3NTZrm7u6O8PBwnqBMREREFUqJ9uyo1Wro6ekVmK6npwe1Wl3qooiIiIjKSonCTocOHTB27Fjcu3dPmnb37l2MHz8eHTt2LLPiiIiIiEqrRGFn8eLFSEtLQ+3atVGnTh3UqVMHjo6OSEtLw6JFi8q6RiIiIqISK9E5O/b29vj777+xb98+XLlyBQDg5uYGX1/fMi2OiIiIqLSKtWfnwIEDcHd3R1paGhQKBTp16oTg4GAEBwfDy8sL9evXx//+97/yqpWIiIio2IoVdhYuXIjhw4dDpVIVaDM1NcVHH32E+fPnl1lxRERERKVVrLBz/vx5dO7cuch2Pz8/nDlzptRFEREREZWVYoWdpKSkQi85z1elShXcv3+/1EURERERlZVihZ0aNWrg0qVLRbZfuHABtra2pS6KiIiIqKwUK+x07doVn3/+OTIzMwu0/fvvv5gxYwbefvvtMiuOiIiIqLSKden5tGnTsHnzZjg7O2PMmDFwcXEBAFy5cgXh4eHIy8vD1KlTy6VQIiIiopIoVtixtrbG8ePHMWrUKISEhEAIAQBQKBTw9/dHeHg4rK2ty6VQIiIiopIo9k0FHRwcsHPnTjx+/BjXr1+HEAL16tVDtWrVyqM+IiIiolIp0R2UAaBatWrw8vIqy1qIiIiIylyJvhuLiIiI6E3BsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREssawQ0RERLLGsENERESyptWwc+TIEXTr1g12dnZQKBTYunWrRvugQYOgUCg0Hp07d9bo8+jRI/Tv3x8qlQpmZmYYOnQo0tPTX+NSEBERUUWm1bDz9OlTNGrUCOHh4UX26dy5MxISEqTH+vXrNdr79++P6Oho7N27Fzt27MCRI0cwYsSI8i6diIiI3hBVtDnzLl26oEuXLi/so6+vDxsbm0LbYmJiEBkZib/++gvNmjUDACxatAhdu3bFN998Azs7uzKvmYiIiN4sFf6cnUOHDsHKygouLi4YNWoUHj58KLVFRUXBzMxMCjoA4OvrCx0dHZw8ebLIMbOyspCWlqbxICIiInmq0GGnc+fO+Omnn7B//37MmzcPhw8fRpcuXZCXlwcASExMhJWVlcZrqlSpAnNzcyQmJhY5blhYGExNTaWHvb19uS4HERERaY9WD2O9TN++faX/N2zYEB4eHqhTpw4OHTqEjh07lnjckJAQTJgwQXqelpbGwENERCRTFXrPzn85OTnBwsIC169fBwDY2NggOTlZo09ubi4ePXpU5Hk+wLPzgFQqlcaDiIiI5OmNCjt37tzBw4cPYWtrCwDw9vZGSkoKzpw5I/U5cOAA1Go1WrRooa0yiYiIqALR6mGs9PR0aS8NAMTFxeHcuXMwNzeHubk5Zs6cid69e8PGxgaxsbH45JNPULduXfj7+wMA3Nzc0LlzZwwfPhzLli1DTk4OxowZg759+/JKLCIiIgKg5T07p0+fRuPGjdG4cWMAwIQJE9C4cWNMnz4durq6uHDhArp37w5nZ2cMHToUTZs2xf/+9z/o6+tLY6xduxaurq7o2LEjunbtijZt2mD58uXaWiQiIiKqYLS6Z6ddu3YQQhTZvnv37peOYW5ujnXr1pVlWURERCQjb9Q5O0RERETFxbBDREREssawQ0RERLLGsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREsqbV78YiIpK72pmV87v7bmq7AKLncM8OERERyRrDDhEREckaww4RERHJGsMOERERyRrDDhEREckaww4RERHJGsMOERERyRrDDhEREckabypI9JrxJnNERK8Xww4REVEZ4YeZiomHsYiIiEjWGHaIiIhI1hh2iIiISNYYdoiIiEjWGHaIiIhI1hh2iIiISNZ46XkFwEsViYiIyg/37BAREZGsMewQERGRrDHsEBERkawx7BAREZGsMewQERGRrDHsEBERkawx7BAREZGsMewQERGRrGk17Bw5cgTdunWDnZ0dFAoFtm7dqtEuhMD06dNha2sLQ0ND+Pr64tq1axp9Hj16hP79+0OlUsHMzAxDhw5Fenr6a1wKIiIiqsi0GnaePn2KRo0aITw8vND2r776Ct9//z2WLVuGkydPwtjYGP7+/sjMzJT69O/fH9HR0di7dy927NiBI0eOYMSIEa9rEYiIiKiC0+rXRXTp0gVdunQptE0IgYULF2LatGno0aMHAOCnn36CtbU1tm7dir59+yImJgaRkZH466+/0KxZMwDAokWL0LVrV3zzzTews7N7bctCREREFVOFPWcnLi4OiYmJ8PX1laaZmpqiRYsWiIqKAgBERUXBzMxMCjoA4OvrCx0dHZw8ebLIsbOyspCWlqbxICIiInmqsGEnMTERAGBtba0x3draWmpLTEyElZWVRnuVKlVgbm4u9SlMWFgYTE1NpYe9vX0ZV09EREQVRYUNO+UpJCQEqamp0uP27dvaLomIiIjKSYUNOzY2NgCApKQkjelJSUlSm42NDZKTkzXac3Nz8ejRI6lPYfT19aFSqTQeREREJE8VNuw4OjrCxsYG+/fvl6alpaXh5MmT8Pb2BgB4e3sjJSUFZ86ckfocOHAAarUaLVq0eO01ExERUcWj1aux0tPTcf36del5XFwczp07B3Nzc9SqVQvjxo3DF198gXr16sHR0RGff/457Ozs0LNnTwCAm5sbOnfujOHDh2PZsmXIycnBmDFj0LdvX16JRURERAC0HHZOnz6N9u3bS88nTJgAAAgMDMTq1avxySef4OnTpxgxYgRSUlLQpk0bREZGwsDAQHrN2rVrMWbMGHTs2BE6Ojro3bs3vv/++9e+LERERFQxaTXstGvXDkKIItsVCgVmzZqFWbNmFdnH3Nwc69atK4/yiIiISAYq7Dk7RERERGWBYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZK1Ch53Q0FAoFAqNh6urq9SemZmJoKAgVK9eHSYmJujduzeSkpK0WDERERFVNBU67ABA/fr1kZCQID2OHj0qtY0fPx5//PEHfvvtNxw+fBj37t1Dr169tFgtERERVTRVtF3Ay1SpUgU2NjYFpqempmLlypVYt24dOnToAACIiIiAm5sbTpw4gZYtW77uUomIiKgCqvB7dq5duwY7Ozs4OTmhf//+iI+PBwCcOXMGOTk58PX1lfq6urqiVq1aiIqK0la5REREVMFU6D07LVq0wOrVq+Hi4oKEhATMnDkTb731Fi5duoTExEQolUqYmZlpvMba2hqJiYkvHDcrKwtZWVnS87S0tPIon4iIiCqACh12unTpIv3fw8MDLVq0gIODAzZu3AhDQ8MSjxsWFoaZM2eWRYlERERUwVX4w1jPMzMzg7OzM65fvw4bGxtkZ2cjJSVFo09SUlKh5/g8LyQkBKmpqdLj9u3b5Vg1ERERadMbFXbS09MRGxsLW1tbNG3aFHp6eti/f7/UfvXqVcTHx8Pb2/uF4+jr60OlUmk8iIiISJ4q9GGsSZMmoVu3bnBwcMC9e/cwY8YM6Orqol+/fjA1NcXQoUMxYcIEmJubQ6VSITg4GN7e3rwSi4iIiCQVOuzcuXMH/fr1w8OHD2FpaYk2bdrgxIkTsLS0BAAsWLAAOjo66N27N7KysuDv748lS5ZouWoiIiKqSCp02Pn1119f2G5gYIDw8HCEh4e/poqIiIjoTfNGnbNDREREVFwMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGuyCTvh4eGoXbs2DAwM0KJFC5w6dUrbJREREVEFIIuws2HDBkyYMAEzZszA33//jUaNGsHf3x/JycnaLo2IiIi0TBZhZ/78+Rg+fDgGDx4Md3d3LFu2DEZGRli1apW2SyMiIiIte+PDTnZ2Ns6cOQNfX19pmo6ODnx9fREVFaXFyoiIiKgiqKLtAkrrwYMHyMvLg7W1tcZ0a2trXLlypdDXZGVlISsrS3qempoKAEhLSyu/Ql9AnZWhlflqm7bWt7bx/a5c+H5XLny/tTNfIcQL+73xYackwsLCMHPmzALT7e3ttVBN5WW6UNsV0OvE97ty4ftduWj7/X7y5AlMTU2LbH/jw46FhQV0dXWRlJSkMT0pKQk2NjaFviYkJAQTJkyQnqvVajx69AjVq1eHQqEo13orkrS0NNjb2+P27dtQqVTaLofKGd/vyoXvd+VSWd9vIQSePHkCOzu7F/Z748OOUqlE06ZNsX//fvTs2RPAs/Cyf/9+jBkzptDX6OvrQ19fX2OamZlZOVdacalUqkr1w1HZ8f2uXPh+Vy6V8f1+0R6dfG982AGACRMmIDAwEM2aNUPz5s2xcOFCPH36FIMHD9Z2aURERKRlsgg777//Pu7fv4/p06cjMTERnp6eiIyMLHDSMhEREVU+sgg7ADBmzJgiD1tR4fT19TFjxowCh/RInvh+Vy58vysXvt8vphAvu16LiIiI6A32xt9UkIiIiOhFGHaIiIhI1hh2iIiISNYYdioxnq5FRESVAcNOJaavr4+YmBhtl0FERFSuZHPpORXt+a/GeF5eXh7mzp2L6tWrAwDmz5//Osui1+jp06fYuHEjrl+/DltbW/Tr109634nozRIcHIw+ffrgrbfe0nYpbwxeel4J6OjooFGjRgW+EuPw4cNo1qwZjI2NoVAocODAAe0USGXO3d0dR48ehbm5OW7fvo22bdvi8ePHcHZ2RmxsLKpUqYITJ07A0dFR26VSGfj7779RrVo16f38+eefsWzZMsTHx8PBwQFjxoxB3759tVwllRUdHR0oFArUqVMHQ4cORWBgYJHfBUnP8DBWJTBnzhykpqbi888/x8GDB6WHrq4uVq9ejYMHDzLoyMyVK1eQm5sL4NkX39rZ2eHWrVs4deoUbt26BQ8PD0ydOlXLVVJZGTx4MGJjYwEAP/74Iz766CM0a9YMU6dOhZeXF4YPH45Vq1ZpuUoqS3v27EHXrl3xzTffoFatWujRowd27NgBtVqt7dIqJkGVwqlTp4Szs7OYOHGiyM7OFkIIUaVKFREdHa3lyqg8KBQKkZSUJIQQwsnJSezZs0ej/dixY8Le3l4bpVE5MDQ0FDdv3hRCCNG4cWOxfPlyjfa1a9cKd3d3bZRG5eD5n+/s7GyxYcMG4e/vL3R1dYWdnZ347LPPxLVr17RcZcXCPTuVhJeXF86cOYP79++jWbNmuHTpEhQKhbbLonKU//5mZmbC1tZWo61GjRq4f/++NsqicmBkZIQHDx4AAO7evYvmzZtrtLdo0QJxcXHaKI3KmZ6eHvr06YPIyEjcuHEDw4cPx9q1a+Hi4qLt0ioUhp1KxMTEBGvWrEFISAh8fX2Rl5en7ZKoHHXs2BFNmjRBWloarl69qtF269YtnqAsI126dMHSpUsBAD4+Pti0aZNG+8aNG1G3bl1tlEavUa1atRAaGoq4uDhERkZqu5wKhVdjVUJ9+/ZFmzZtcObMGTg4OGi7HCoHM2bM0HhuYmKi8fyPP/7glRwyMm/ePLRu3Ro+Pj5o1qwZvv32Wxw6dAhubm64evUqTpw4gS1btmi7TCojDg4O0NXVLbJdoVCgU6dOr7Giio9XYxERyUBKSgrmzp2LP/74Azdu3IBarYatrS1at26N8ePHo1mzZtoukUhrGHaIiIhI1njODhEREckaww4RERHJGsMOERERyRrDDhFVCAqFAlu3btV2GUQkQww7RJXE7du3MWTIENjZ2UGpVMLBwQFjx47Fw4cPX2sdoaGh8PT0LDA9ISEBXbp0Kff5Z2dn46uvvkKjRo1gZGQECwsLtG7dGhEREcjJyXmlMW7evAmFQoFz586Vb7FEVCZ4nx2iSuDGjRvw9vaGs7Mz1q9fD0dHR0RHR2Py5MnYtWsXTpw4AXNzc63W+Dq+yDA7Oxv+/v44f/48Zs+ejdatW0OlUuHEiRP45ptv0Lhx40KDWEWXnZ0NpVKp7TKIKi7tflsFEb0OnTt3FjVr1hQZGRka0xMSEoSRkZEYOXKkNA2A2LJli0Y/U1NTERERIT2Pj48X7733njA1NRXVqlUT3bt3F3FxcVL7wYMHhZeXlzAyMhKmpqaiVatW4ubNmyIiIkIA0Hjkj/vf+V64cEG0b99eGBgYCHNzczF8+HDx5MkTqT0wMFD06NFDfP3118LGxkaYm5uL0aNHS9/9Vph58+YJHR0d8ffffxdoy87OFunp6UIIIXbt2iVat24tTE1Nhbm5uQgICBDXr1/XWEfPP3x8fKS2FStWCFdXV6Gvry9cXFxEeHi4xnyOHTsmGjVqJPT19UXTpk3Fli1bBABx9uxZqc+hQ4eEl5eXUCqVwsbGRkyZMkXk5ORI7T4+PiIoKEiMHTtWVK9eXbRr104MHjxYBAQEFFgmS0tL8eOPPxa5TogqA4YdIpl7+PChUCgUYs6cOYW2Dx8+XFSrVk2o1WohxMvDTnZ2tnBzcxNDhgwRFy5cEJcvXxYffPCBcHFxEVlZWSInJ0eYmpqKSZMmievXr4vLly+L1atXi1u3bomMjAwxceJEUb9+fZGQkCASEhKkAPb8fNPT04Wtra3o1auXuHjxoti/f79wdHQUgYGBUk2BgYFCpVKJkSNHipiYGPHHH38IIyOjAl+C+TwPDw/h5+f30nW2adMm8fvvv4tr166Js2fPim7duomGDRuKvLw8IcSzL9YFIPbt2ycSEhLEw4cPhRBC/PLLL8LW1lb8/vvv4saNG+L3338X5ubmYvXq1UIIIVJTU4W5ubn48MMPRXR0tNi5c6dwdnbWCDt37twRRkZGYvTo0SImJkZs2bJFWFhYiBkzZkj1+fj4CBMTEzF58mRx5coVceXKFXHs2DGhq6sr7t27J/XbvHmzMDY21giJRJURww6RzJ04caLQAJNv/vz5AoD0LcovCzs///yzcHFxkcKREEJkZWUJQ0NDsXv3bvHw4UMBQBw6dKjQ+c2YMUM0atSowPTn57t8+XJRrVo1aU+LEEL8+eefQkdHRyQmJgohnoUdBwcHkZubK/V57733xPvvv1/kujA0NBQff/xxke1FuX//vgAgLl68KIQQIi4ursDeGCGEqFOnjli3bp3GtNmzZwtvb28hhBBLly4V1atXF//++6/UvmLFCo2xPvvsswLrNzw8XJiYmEhhy8fHRzRu3LhAne7u7mLevHnS827duolBgwYVe3mJ5IYnKBNVEuIlN0t/1XM+zp8/j+vXr6Nq1aowMTGBiYkJzM3NkZmZidjYWJibm2PQoEHw9/dHt27d8N133yEhIaFYtcbExKBRo0YwNjaWprVu3RpqtVrjS03r16+v8R1Btra2SE5OLnLcl62DfNeuXUO/fv3g5OQElUqF2rVrAwDi4+OLfM3Tp08RGxuLoUOHSuvFxMQEX3zxBWJjYwEAV69ehYeHBwwMDKTX/fcbymNiYuDt7S19a33+sqenp+POnTvStKZNmxaoYdiwYYiIiAAAJCUlYdeuXRgyZMgrLTORnPEEZSKZq1u3LhQKBWJiYvDOO+8UaI+JiYGlpSXMzMwAPLsE/L+h4PmrlNLT09G0aVOsXbu2wFiWlpYAgIiICHz88ceIjIzEhg0bMG3aNOzduxctW7YswyUD9PT0NJ4rFAqo1eoi+zs7O+PKlSsvHbdbt25wcHDAihUrYGdnB7VajQYNGiA7O7vI16SnpwMAVqxYgRYtWmi0vehLG0vq+SCYb+DAgfj0008RFRWF48ePw9HRkV/4SgReek4ke9WrV0enTp2wZMkS/PvvvxptiYmJWLt2LQYNGiRNs7S01NgTc+3aNWRkZEjPmzRpgmvXrsHKygp169bVeJiamkr9GjdujJCQEBw/fhwNGjTAunXrADzbg5SXl/fCmt3c3HD+/Hk8ffpUmnbs2DHo6OjAxcWlROsBAD744APs27cPZ8+eLdCWk5ODp0+f4uHDh7h69SqmTZuGjh07ws3NDY8fP9bom78X7PnlsLa2hp2dHW7cuFFgvTg6OgIAXFxccPHiRWRlZUmv++uvvwose1RUlEbgPHbsGKpWrYqaNWu+cPmqV6+Onj17IiIiAqtXr8bgwYNfcc0QyRvDDlElsHjxYmRlZcHf3x9HjhzB7du3ERkZiU6dOsHZ2RnTp0+X+nbo0AGLFy/G2bNncfr0aYwcOVJjD0r//v1hYWGBHj164H//+x/i4uJw6NAhfPzxx7hz5w7i4uIQEhKCqKgo3Lp1C3v27MG1a9fg5uYGAKhduzbi4uJw7tw5PHjwQOMP//PzMDAwQGBgIC5duoSDBw8iODgYAwYMgLW1dYnXw7hx49C6dWt07NgR4eHhOH/+PG7cuIGNGzeiZcuWuHbtGqpVq4bq1atj+fLluH79Og4cOIAJEyZojGNlZQVDQ0NERkYiKSkJqampAICZM2ciLCwM33//Pf755x9cvHgRERERmD9/PoBnYUutVmPEiBGIiYnB7t278c033wCAdNhq9OjRuH37NoKDg3HlyhVs27YNM2bMwIQJE6Cj8/Jf2cOGDcOaNWsQExODwMDAEq8rIlnR7ilDRPS6xMXFicDAQGFtbS0UCoUAIHr16iWePn2q0e/u3bvCz89PGBsbi3r16omdO3cWuPQ8ISFBDBw4UFhYWAh9fX3h5OQkhg8fLlJTU0ViYqLo2bOnsLW1FUqlUjg4OIjp06dLJ9dmZmaK3r17CzMzszK59Px5Y8eO1bgMvDCZmZkiLCxMNGzYUBq7devWYvXq1dLl3Xv37hVubm5CX19feHh4iEOHDhWob8WKFcLe3l7o6OhozHPt2rXC09NTKJVKUa1aNdG2bVuxefNmqf3YsWPCw8NDKJVK0bRpU7Fu3ToBQFy5ckXq8yqXno8dO7bQ5VOr1cLBwUF07dr1heuBqDJRCPGKZ+wRkazMmDED8+fPL5dzaejVrV27FoMHD0ZqaioMDQ1LPV56ejpq1KiBiIgI9OrVqwwqJHrz8QRlokpq5syZqF27Nk6cOIHmzZu/0iESKr2ffvoJTk5OqFGjBs6fP48pU6agT58+pQ46arUaDx48wLfffgszMzN07969jComevMx7BBVYjyB9fVLTEzE9OnTkZiYCFtbW7z33nv48ssvSz1ufHw8HB0dUbNmTaxevRpVqvDXO1E+HsYiIiIiWeN+ayIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikrX/Bwaqons2vA8pAAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "unique_temperatures = no_stem_summary_df[\"Temperature\"].unique()\n",
    "\n",
    "for temp in unique_temperatures:\n",
    "    temp_df = no_stem_summary_df[no_stem_summary_df[\"Temperature\"] == temp]\n",
    "\n",
    "    temp_df.plot(kind=\"bar\", stacked=True)\n",
    "\n",
    "    plt.title(f\"Sum of counts across categories for temperature {temp}\")\n",
    "    plt.xlabel(\"Question Category\")\n",
    "    plt.ylabel(\"Count\")\n",
    "\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Brand vs Preferred\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for effective with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [02:04<00:00,  2.96it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for safe with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [02:05<00:00,  2.92it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for associated with side effects with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [02:01<00:00,  3.02it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for likely to make me sick with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [02:02<00:00,  3.00it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for effective with temperature 1.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [02:01<00:00,  3.03it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for safe with temperature 1.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [01:59<00:00,  3.06it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for associated with side effects with temperature 1.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [02:01<00:00,  3.03it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for likely to make me sick with temperature 1.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [01:59<00:00,  3.08it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for effective with temperature 2.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [02:06<00:00,  2.91it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for safe with temperature 2.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [02:02<00:00,  3.00it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for associated with side effects with temperature 2.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [02:03<00:00,  2.96it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for likely to make me sick with temperature 2.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 367/367 [01:57<00:00,  3.12it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "dict_keys(['temp_0_0', 'temp_1_0', 'temp_2_0'])"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "stem_df = perform_inference(\n",
    "    processed_df_with_stem,\n",
    "    question_categories,\n",
    "    temperatures,\n",
    "    get_chat_completion,\n",
    "    stem=True,\n",
    "    debug=DEBUG,\n",
    ")\n",
    "\n",
    "stem_df.keys()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "   Temperature             Question Category  Preferred  Brand  No Choice\n",
      "0          0_0                     effective        173    177          0\n",
      "1          0_0                          safe        183    184          0\n",
      "2          0_0  associated with side effects        171    196          0\n",
      "3          0_0        likely to make me sick        187    155          0\n",
      "4          1_0                     effective        172    177          0\n",
      "5          1_0                          safe        183    184          0\n",
      "6          1_0  associated with side effects        171    196          0\n",
      "7          1_0        likely to make me sick        185    155          0\n",
      "8          2_0                     effective        173    177          0\n",
      "9          2_0                          safe        183    184          0\n",
      "10         2_0  associated with side effects        171    196          0\n",
      "11         2_0        likely to make me sick        185    155          0\n"
     ]
    }
   ],
   "source": [
    "stem_summary_df = summarize_choices(stem_df, question_categories, stem=True)\n",
    "print(stem_summary_df)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Plot\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "unique_temperatures = stem_summary_df[\"Temperature\"].unique()\n",
    "\n",
    "for temp in unique_temperatures:\n",
    "    temp_df = stem_summary_df[stem_summary_df[\"Temperature\"] == temp]\n",
    "\n",
    "    temp_df.plot(kind=\"bar\", stacked=True)\n",
    "\n",
    "    plt.title(f\"Sum of counts across categories for temperature {temp}\")\n",
    "    plt.xlabel(\"Question Category\")\n",
    "    plt.ylabel(\"Count\")\n",
    "\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Save\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Saved DataFrame to ../results/direct_preference/temp_0_0_no_stem_df.csv\n",
      "Saved DataFrame to ../results/direct_preference/temp_1_0_no_stem_df.csv\n",
      "Saved DataFrame to ../results/direct_preference/temp_2_0_no_stem_df.csv\n",
      "Saved DataFrame to ../results/direct_preference/no_stem_summary_df.csv\n"
     ]
    }
   ],
   "source": [
    "# Save the no_stem_dfs\n",
    "for temp_key, temp_df in no_stem_df.items():\n",
    "    # Save the temperature-specific DataFrame\n",
    "    temp_df_filename = os.path.join(output_dir, ENGINE, f\"{temp_key}_no_stem_df.csv\")\n",
    "    temp_df.to_csv(temp_df_filename, index=False)\n",
    "    print(f\"Saved DataFrame to {temp_df_filename}\")\n",
    "\n",
    "# Save the no_stem_summary_df\n",
    "no_stem_summary_df_filename = os.path.join(output_dir, ENGINE, \"no_stem_summary_df.csv\")\n",
    "no_stem_summary_df.to_csv(no_stem_summary_df_filename, index=False)\n",
    "print(f\"Saved DataFrame to {no_stem_summary_df_filename}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Saved DataFrame to ../results/direct_preference/temp_0_0_stem_df.csv\n",
      "Saved DataFrame to ../results/direct_preference/temp_1_0_stem_df.csv\n",
      "Saved DataFrame to ../results/direct_preference/temp_2_0_stem_df.csv\n",
      "Saved DataFrame to ../results/direct_preference/stem_summary_df.csv\n"
     ]
    }
   ],
   "source": [
    "# Save the stem_dfs\n",
    "for temp_key, temp_df in stem_df.items():\n",
    "    # Save the temperature-specific DataFrame\n",
    "    temp_df_filename = os.path.join(output_dir, ENGINE, f\"{temp_key}_stem_df.csv\")\n",
    "    temp_df.to_csv(temp_df_filename, index=False)\n",
    "    print(f\"Saved DataFrame to {temp_df_filename}\")\n",
    "\n",
    "# Save the stem_summary_df\n",
    "stem_summary_df_filename = os.path.join(output_dir, ENGINE, \"stem_summary_df.csv\")\n",
    "stem_summary_df.to_csv(stem_summary_df_filename, index=False)\n",
    "print(f\"Saved DataFrame to {stem_summary_df_filename}\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "in_biased_learning",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.18"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
